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This PhD thesis provides an extended summary of work performed at the Center for 
Neuroplasticity and Pain (CNAP), Department of Health Science and Technology, Aalborg 
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The purpose of the thesis was to investigate temporal changes in pain processing mechanisms, 
specifically pressure pain sensitivity, temporal summation of pain and conditioned pain 
modulation, in relation to the experience of low back pain. This was achieved through the 
combined use of meta-analytic, experimental, observational, and interventional approaches. 
The thesis is organised primarily as an overview and discussion of the background, 
methodology, and findings for each of the measures investigated. It synthesises content from 
four journal articles, three of which are already published in international peer-reviewed journals 
and the fourth of which has been submitted. 
Throughout the thesis, these articles are referred to as:  
Systematic Review: ME McPhee, HB Vaegter & T Graven-Nielsen. (2020) Alterations in pro-
nociceptive and anti-nociceptive mechanisms in patients with low back pain: A systematic 
review with meta-analysis. PAIN, 161: 464-475. DOI: 10.1097/j.pain.0000000000001737 
Study I: ME McPhee & T Graven-Nielsen. (2019) Alterations in Temporal Summation of Pain 
and Conditioned Pain Modulation across an Episode of Experimental Exercise-Induced Low 
Back Pain. The Journal of Pain, 20(3):264-276. DOI: 10.1016/j.jpain.2018.08.010 
Study II:  ME McPhee & T Graven-Nielsen. (2019) Recurrent low back pain patients 
demonstrate facilitated pro-nociceptive mechanisms when in pain, and impaired anti-
nociceptive mechanisms with and without pain. PAIN, 160: 2866-2876. DOI: 
10.1097/j.pain.0000000000001679 
Study III: ME McPhee & T Graven-Nielsen. (Submitted) Medial Prefrontal High-Definition 
Transcranial Direct Current Stimulation to Improve Pain Modulation in Chronic Low Back Pain: 
A Pilot Randomized Double-blind Crossover Trial
VII 
ENGLISH SUMMARY 
Low back pain (LBP) has afflicted humans for thousands of years and today remains a leading 
cause of disability globally. The vast majority of LBP cases are classified as non-specific, 
meaning no clear pathophysiology has been identified. With this in mind, increased focus has 
been on illuminating some of the underlying mechanisms and drivers of LBP. During the past 
decades, measures of pain sensitivity, such as local and widespread hypersensitivity to 
pressure, temporal summation of pain (TSP), and conditioned pain modulation (CPM), have 
gained special interest and may reflect mechanisms that are now commonly acknowledged to 
play an important role in LBP. On this basis, a plethora of studies have been published in the 
past two decades looking either at cross-sectional differences in pain sensitivity measures 
between LBP patients and controls, or at the utility of these measures in predicting longer-term 
prognosis. Unfortunately, results of such studies have been highly inconsistent, hence it has 
remained unclear to what extent alterations in these mechanisms are present among LBP 
populations. In addition, many existing studies have reported pain sensitivity measures at only 
one timepoint, when patients were already in pain, making it unclear as to how these measures 
change over time in relation to the development and/or resolution of LBP.  
The present thesis set out to further investigate this temporal relationship between central pain 
processing mechanisms and LBP experience. To do so, a systematic review and meta-analysis 
along with three experimental studies were planned and conducted to approach this 
relationship from four different angles. A meta-analysis of existing studies was performed to 
quantify the magnitude of alterations in TSP and CPM among LBP patients compared to 
controls, as well as to explore potential associations between these measures and pain 
severity/duration. Study I took healthy pain-free individuals and induced experimental LBP, by 
having participants perform fatiguing exercise, allowing for investigation of both pain-free 
baseline predictors of LBP development and changes in pressure pain sensitivity, TSP and 
CPM across a short-lasting experimental episode of LBP. Study II recruited patients with 
recurrent LBP, along with matched controls, and assessed pressure pain sensitivity, CPM and 
TSP both during a painful episode and when naturally recovered to pain-free. Finally, Study III 
took patients with chronic LBP and used a transcranial direct current stimulation (tDCS) 
paradigm to target cortical regions involved in pain-modulatory circuitry, and sham comparator, 
allowing for assessment of changes in pressure pain sensitivity, TSP and CPM in relation to 
changes in pain.  
In addition to the primary outcomes, various factors that could influence both pain experience 
and central pain processing, namely age, gender, body mass index, sleep, mood, menstruation, 
anxiety, pain catastrophizing and physical activity, were captured across experimental studies 
(I-III). However, these factors rarely differed significantly between patient and control groups or 
between painful and pain-free sessions. A range of clinical variables were also recorded for 
LBP patient groups over the study periods, including the intensity, unpleasantness, duration, 
quality, and distribution of pain, as well as related disability (Study I-III). Of course, pain 
durations and disability levels were higher in LBP patients with increasing duration of pain than 
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for participants with experimental LBP, but the intensity, unpleasantness, and distribution of 
LBP was similar between experimental, recurrent, and chronic LBP groups during painful 
testing sessions (Study I-III).  
The meta-analysis demonstrated that clear differences in TSP and CPM exist overall between 
LBP patients and controls, though the magnitude of these differences was small. Further, 
alterations in TSP were weakly related to pain severity, while CPM impairment showed relation 
to both pain duration and severity. Study I highlighted that mild experimental LBP provoked 
reductions in local and distant hypersensitivity to pressure but was not sufficient in intensity or 
duration to significantly affect TSP or CPM. Baseline pain-free TSP did, however, show some 
relation to the severity of LBP developed. Study II showed that, during a recurrent LBP episode, 
patients demonstrated local and widespread pressure hyperalgesia and facilitated TSP 
compared to controls, but this resolved when pain-free. On the contrary, CPM was impaired in 
recurrent LBP patients compared to controls overall regardless of pain status. Finally, Study III 
demonstrated similar patterns of change in pressure pain sensitivity and TSP in relation to pain 
status as Study I-II, though CPM did not appear to be impaired in this group and remained 
unchanged across the study period. Unfortunately, the tDCS paradigm selected was largely 
ineffective though, perhaps due to the already functioning descending inhibition in this group. 
When taken together, findings from the present work would suggest that local and widespread 
hyperalgesia to pressure is primarily a consequence of the presence of LBP. Similarly, though 
TSP may have a small degree of predictive value for prognosis when assessed in a pain-free 
state, it seems that the facilitation observed in patients is also consequential to ongoing pain. 
CPM, on the other hand, seemed less impacted by pain presence per se and instead may 
deteriorate over time in LBP patients. The strength and generalisability of these conclusions 
are, however, limited by the considerable inter- and intra-individual variation in pain sensitivity 
measures, the selectivity of recruitment and the small experimental samples included. 
Nonetheless, this work has provided a comprehensive approach to understanding the influence 
of LBP presence on pain sensitivity measures, which can easily be applied to various other 
outcomes and conditions. This work has also clarified certain aspects of the relationship 
between measures of pain sensitivity and LBP presence, suggesting these measures may be 
important in tracking fluctuations in LBP conditions and/or predicting pain and treatment 
prognosis, though future work is required to explore these potential utilities.    
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DANSK RESUME 
Lænderygsmerter har plaget mennesker i tusinde år og er i dag fortsat den største grund til nedsat 
funktionsevne blandt den globale befolkning. Den største andel af lænderygsmerter er kategoriseret 
som uspecifikke, dvs. at der ikke er en tydelig forklaring på hvorfor at smerterne opstår. På grund af 
dette har der været et øget fokus på at belyse nogle af de underliggende mekanismer, der om muligt 
kan bidrage til at lænderygsmerter udvikles. Gennem de seneste årtier har målinger af 
smertesensitivitet, såsom lokalt og udbredt smerteoverfølsomhed over for tryk 
(trykhypersensitivitet), ændringer i opfattelsen af faciliteret smertepåvirkning (Temporal summation 
of pain/TSP) og konditioneret smertemodulering (Conditioned pain modulation/CPM), fået særlig 
opmærksomhed, da disse afspejler mekanismer, der nu anderkendes at spille en vigtig rolle i 
lænderygsmerter. Et væld af studier er blevet offentliggjort inden for de sidste to årtier. Disse 
undersøger enten forskelle i smertemekanismerne mellem patienter med lænderygsmerter og 
kontrol deltagere eller hvorvidt, disse målinger kan bruges til at forudse en prognose på længere 
sigt. Desværre har resultaterne af disse studier været modstridende, og det er dermed fortsat uklart 
i hvilken grad sådanne ændringer i disse mekanismer er til stede hos patienter med 
lænderygsmerter. Desuden, rapporterer mange af studierne kun målinger af smertemekanismer på 
et enkelt tidspunkt når deltagerne allerede har smerte, hvilket gør det uklart, om målingerne ændrer 
sig over tid i forhold til udviklingen og/eller forbedringen af rygsmerten.  
Formålet med denne tese er derfor yderligere at undersøge den tidsmæssige sammenhæng mellem 
de central-medierede smertemekanismer og lænderygsmerter. Til dette formål blev der planlagt en 
systematisk litteraturgennemgang med tilhørende meta-analyse samt tre eksperimentelle studier 
planlagt og udført for netop at belyse denne sammenhæng ud fra fire forskellige vinkler. Meta-
analysen af eksisterende studier var udført for at identificere forskelle i ændringer af TSP- og CPM-
målinger blandt patienter med lænderygsmerter i forhold til kontrol deltagere, samt for at udforske 
potentielle sammenhænge mellem disse smertemekanismer og smerteintensitet eller varighed. I 
studie I blev lænderygsmerter induceret i raske og smertefrie deltagere via hjælp af en trænings-
induceret smertemodel, der fremkaldte træningsømhed i lænden. Dette gjorde det muligt at 
undersøge både hvordan smertefrie målinger kunne bruges til at forudse lænderygsmerternes 
udvikling og hvordan tryksmertetærskler (PPTs), TSP og CPM ændrer sig over en kortvarigt 
eksperimentel episode af lænderygsmerter. I studie II blev patienter med tilbagevendende 
lænderygsmerter rekrutteret sammen med matchede kontrol-deltagere. PPTs, CPM og TSP blev 
derefter målt både under en smertefuld episode og når de naturligt blev smertefrie igen. Endeligt, 
studie III involverede patienter med kroniske lænderygsmerter og her blev det forsøgt at mindske 
deres smerter ved hjælp af et trans-kranie jævnstrømsstimulerings protokol (tDCS), der var målrettet 
de hjerneregioner, der er involveret i smertemodulering og derved gør det muligt at vurdere 
ændringer i PPTs, TSP og CPM i forbindelse med ændringer i smerten. 
Foruden de primære udfald blev en række faktorer, der kunne påvirke både smerte oplevelsen og 
målingen af smertemekanismer (heraf alder, køn, kropsmasse indeks (BMI), søvn, humør, 
menstruation, angst, smertekatastrofetænkning og fysisk aktivitet) registreret over tid i alle 
eksperimentelle studier (I-III). Disse faktorer viste dog sjældent signifikante forskelle mellem de to 
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grupper (patient og kontrol) eller mellem de smertefulde og smertefrie episoder. En række kliniske 
variabler blev også registreret for patienterne med lænderygsmerter over studieperioderne. Disse 
inkluderede intensiteter, ubehagelighed, varighed, kvalitet, og område af smerte og relateret 
funktionsniveau (Studier I-III). Som forventet varede smerter over længere tid og forårsagede en 
større grad af funktionsnedsættelse blandt patienterne med kliniske lænderygsmerter i forhold til de 
kontrol-deltagere med eksperimentelt-induceret lænderygsmerter. Dog var smerte-intensitet, -
ubehag og -område forholdsvis sammenlignelige mellem grupperne under de smertefulde episoder 
(Studie I-III).  
Meta-analysen demonstrerede overordnede tydelige forskelle i TSP og CPM mellem patienter med 
lænderygsmerter og kontrol deltagere, selvom størrelsen af disse forskelle var forholdsvis små. 
Desuden var ændringer i TSP svagt relateret til smerteintensitet, mens reduceret var relateret til 
både smertevarighed og smerteintensitet. Studie I viste, at mild eksperimentelt-induceret 
lænderygsmerter fremkaldte både en lokal og udbredt trykhypersensitivitet, men disse var ikke 
intense eller langvarige nok til at forårsage væsentlige ændringer i TSP eller CPM væsentlig. Dog 
viste TSP ved start, uden smerte, nogen sammenhæng med intensiteten af de udviklede 
lænderygsmerter. Studie II viste, at patienter under en episode af tilbagevendende lænderygsmerter 
også udviste lokalt og udbredt trykhypersensitivitet samt øget TSP sammenlignet med kontrol-
deltagerne, men at dette normaliseret i en smertefri periode. I modsætning til dette var CPM generelt 
reduceret hos dem med tilbagevendende lænderygsmerter uanset smertestatus når disse blev 
sammenlignet med kontrol-deltagere. Endeligt, viste studie III lignende ændringsmønstrer i både 
tryksensitivitet og TSP i forhold til smerte status som i studier I-II. Dog forblev CPM uændret blandt 
denne patientgruppe under hele undersøgelsesperioden. Desværre var den valgte tDCS protokol 
ineffektiv, hvilket måske kan skyldes en allerede fungerende smerteinhiberende mekanisme (CPM) 
blandt denne gruppe. 
Samlet set antyder resultaterne fra denne tese, at både en lokal og udbredt trykhypersensitivitet 
primært er en konsekvens af lænderygsmerternes tilstedeværelse. På trods af at TSP, til en vis 
grad, kan bruges som prædiktiv faktor i forhold til prognosen, når denne måles/vurderes under en 
smertefri tilstand/episode, ser det ud til, at den observerede facilitering hos patienterne er en følge 
af de vedvarende smerter. CPM virkede derimod mindre påvirket af smerternes tilstedeværelse og 
syntes i stedet at forværres over tid hos patienterne med lænderygsmerter. Styrken og 
generaliserbarheden af disse konklusioner er dog begrænset af den betydelige inter- og intra-
individuelle variation i målingerne, selektiviteten af rekruttering og de få deltagere inkluderet. Ikke 
desto mindre har dette arbejde betydeligt øget forståelse af, hvordan lænderygsmerters 
tilstedeværelse kan påvirke eller influere på forskellige målinger, der på lignede vis let kan overføres 
og anvendes til at undersøge andre målinger eller andre sygdomstilstande. Denne tese har således 
afklaret visse aspekter af forholdet mellem forskellige målinger af smertemekanismer og det 
tidsmæssige perspektiv af lænderygsmerternes tilstedeværelse, hvilket tyder på, at disse målinger 
kan være vigtige for at spore ændringer og/eller forudsige smerte og behandlingsprognose. 
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TABLE OF ABBREVIATIONS & TERMS 
BMI – Body mass index 
CPM – Conditioned pain modulation 
DOMS – Delayed onset muscle soreness 
ECR – Extensor carpi radialis brevis (muscle) 
eVAS – electronic Visual Analogue Scale 
GAS – Gastrocnemius (muscle) 
LBP – Low back pain (RLBP = recurrent, CLBP = chronic) 
cPDT – Pain detection threshold (cuff) 
PPT – Pressure pain threshold (handheld) 
cPTT – Pain tolerance threshold (cuff)  
QST – Quantitative sensory testing 
TSP – Temporal summation of pain 
UT – Upper trapezius  (muscle) 
‘Pain sensitivity’ is used throughout the thesis as an umbrella term to refer to pressure pain 
detection and tolerance thresholds, suprathreshold simulation ratings, temporal summation of 
pain and conditioned pain modulation.  
‘Pressure pain sensitivity’ is used throughout the thesis to indicate only basal measures of 
pressure pain detection and tolerance thresholds, and ratings to individual suprathreshold 
pressure stimuli.  
‘Hypersensitivity’ is used to throughout the thesis to indicate that either, a stimulus of the 
same intensity is now perceived to be more painful, or the point at which a stimulus becomes 
uncomfortable or painful is now lower than it was previously.  
‘Central pain processing mechanisms’ is used throughout the thesis to cover mechanisms 
including, but not limited to, wind-up processes underlying temporal summation of pain and 
descending inhibitory processes underlying conditioned pain modulation. 
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CHAPTER 1. A BRIEF INTRODUCTION TO 
PAIN SENSITIVITY IN LOW BACK PAIN 
Low back pain (LBP) has been plaguing humans for thousands of years, with back pain 
management guidelines being discovered in Ancient Egypt from as early as 1600BC336. 
However, it is only in relatively recent times that a concerted research effort has been made to 
quantify the extent and impact of this condition. In 2017, the Global Burden of Diseases 
study67,359 estimated the global point prevalence of disabling LBP at 8.5%, making it the world’s 
leading cause of Years Lived with Disability. As a condition, it represents a significant source 
of economic burden, on the basis of increased health-care utilisation and lost productivity186,189, 
even when best-practice guidelines are followed177, not to mention obvious negative personal 
consequences.  
1.1. DEFINING & CLASSIFYING LOW BACK PAIN 
For many years, researchers have debated how to best define and classify the heterogeneous 
population reporting pain in the lower back region35,66,167,244. In its simplest form, one defines 
LBP as the presence of pain in the lower portion of the posterior trunk, demarcated superiorly 
by the inferior costal margin and inferiorly by the gluteal fold66. However, LBP can often be 
accompanied by pain radiating down into the legs, by pain from the thoracic and cervical 
regions, or by widespread pain symptoms. Beyond spatial extent, LBP conditions are also often 
classified based on their temporal pattern. Like most painful disorders, the usual distinction 
between acute and chronic LBP is three months, but the commonly recurring nature of LBP123 
has led to more nuanced classifications on the basis of episode frequency, severity, duration 
and care-seeking behaviour135,227,306.  
LBP may also be classified on the basis of presumed source or cause, potential underlying 
mechanisms, or symptom clustering210,238,261,264,285. However, even with the advent of advanced 
imaging techniques and diagnostic testing, there is often unclear correlation between 
symptomatology and identified structural and biochemical abnormalities40. In rare cases (<1%), 
a serious underlying pathology exists119, and LBP is thus attributed to a diagnosis of cancer, 
vertebral fracture, infection or neurological compromise. The majority of remaining cases, 
however, are generally termed non-specific, meaning that a definite source or 
pathophysiological mechanism remains elusive187; and hence, classification is instead based 
on movement patterns, patient history or other clinical testing.  
1.2. UNDERSTANDING THE ROLE OF HYPERSENSITIVITY 
One avenue of interest among pain researchers in recent decades, following the discovery of 
a ‘plastic’ central component in pain163,357, has been the quantification of sensitisation, 
especially in central pain processing mechanisms in patients with painful conditions. This 
sensitisation is often used to explain the discordance between clinical pain reports and 
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observable injury severity, especially in chronic pain conditions. As a result of the lack of clear 
pathophysiological explanation for most patients with LBP, researchers in this field have also 
moved focus away from biomechanical or structural explanations and instead started exploring 
the role of sensitisation, by way of sensory testing. As such, alterations in central pain 
processing mechanisms underlying hypersensitivity, in conjunction with psychosocial factors, 
are now commonly speculated to contribute to LBP development and/or maintenance114, 
though empirical support for this is lacking. 
Sensory testing has been implemented for over a century now326. Nonetheless, the advent of 
standardised testing batteries and development of measures to assess ‘dynamic’ central pain 
processing mechanisms (e.g. temporal summation of pain (TSP) and conditioned pain 
modulation (CPM)) have produced a surge in publications looking at potential diagnostic, 
discriminative and prognostic value. In particular, many cross-sectional studies have been 
performed, generally showing some degree of hypersensitivity (enhanced TSP or impaired 
CPM) in patients with pain when compared to pain-free control participants173,230. At the outset 
of this thesis, however, there was little consensus on whether these mechanisms were actually 
altered in LBP patients specifically. As well, the temporal relationship between LBP experiences 
and possible alterations observed in TSP and CPM was not established. It could be that some 
individuals are at greater susceptibility to developing recurring or persisting LBP due to inherent 
differences in these mechanisms, opening up for predictive and preventative utility, or it could 
be that the alterations observed are a consequence of ongoing pain. 
1.3. AIMS AND HYPOTHESES OF THIS THESIS 
This thesis aimed to clarify the relationship between LBP presence and alterations in pain 
sensitivity measures, with the hope of elucidating whether these alterations are consequential 
to LBP or are maintained despite pain recovery or reduction. More specific objectives were to: 
I) Clarify the existence and magnitude of alterations in pain sensitivity (i.e. TSP 
and CPM) among LBP patient populations in comparison to pain-free controls 
or reference data (Systematic Review & Study II). 
II) Examine the effect of inducing LBP experimentally on pain sensitivity measures 
(i.e. pressure pain thresholds, TSP and CPM) within-individuals (Study I). 
III) Examine the impact of clinical LBP resolution (Study II) or reduction (Study III) 
on pain sensitivity measures within-individuals. 
IV) Compare pain sensitivity between LBP patients and control participants when 
clinical pain is absent (Study II).  
It was hypothesised that when LBP of any kind was present and/or more severe, patients would 
show hypersensitivity to pressure, enhanced TSP and impaired CPM compared to measures 
taken when individuals were pain-free, as well as compared to pain-free control participants.   
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Figure 1-1 Conceptual schematic of the work contained in the present thesis. A systematic review 
and meta-analyses was used to identify if alterations in central pain processing measures were present 
in patients with LBP, then the temporal relation of these alterations to the presence of LBP was probed 
using experimental provocation of LBP (Study I), observation of naturally fluctuating recurrent LBP 
(Study II) and experimental modulation of chronic LBP (Study III). Note: *indicates that these outcomes 
were only included in experimental studies, not the Systematic Review.  
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CHAPTER 2. PROBING TEMPORAL 
ASPECTS OF HYPERSENSITIVITY  
2.1. APPROACHING TEMPORAL RELATIONSHIPS BETWEEN 
PAIN AND HYPERSENSITIVITY 
The current thesis takes four different approaches to investigating how pain sensitivity 
measures and the experience of LBP relate over time. This includes cross-sectional, forward 
provocatory, observational, and backward modulatory methods (Fig 1-1). In theory, this should 
then provide a comprehensive depiction of how alterations in pain processing mechanisms 
relate to state (the presence and characteristics of pain during testing) and/or trait (the clinical 
characteristics of the condition) features of LBP.  
2.1.1. COMPARING CROSS-SECTIONAL DATA  
In the past decade, many studies have emerged comparing patients with LBP to pain-free 
individuals across various measures of pain sensitivity. Surprisingly, however, prior to 2019 no 
large-scale collation and comparison of these studies had been performed. In the first instance, 
meta-analysis of case-control data can provide an indication as to whether pain sensitivity 
measures are altered in patients with LBP and to what extent. Further, when data is available 
for patients in different temporal classifications (i.e. acute, recurrent, chronic) or with differing 
pain durations, the existing literature provides the possibility to perform sub-group and 
correlational analysis, allowing greater insight into theoretical temporal alterations. Although 
this type of analysis comes with many limitations, such as: differing methodologies and 
definitions used between studies, the need to transform variables for comparison, missing or 
unavailable data, and use of group-level outcomes; it still allows broad conclusions to be drawn. 
This approach was used in this thesis as part of a systematic review and meta-analysis on TSP 
and CPM in LBP patients.  
2.1.2. INDUCING EXPERIMENTAL LOW BACK PAIN  
Without large-scale long-term prospective cohort studies of initially pain-free individuals, it is 
challenging to capture patients before they develop a painful condition. However, gaining 
insight into how patients appeared before they had pain is critical to understanding what 
aspects of altered pain sensitivity may precede, coincide with and/or be a consequence of the 
condition. In this way, experimental models of pain offer a unique possibility to track individuals 
before, during and following an ‘episode’, allowing one to test both the impact of pain presence 
on different measures of pain sensitivity, as well as the impact of baseline variation in sensitivity 
on the extent of pain developed.  
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A number of experimental pain models exist, some of which involve injection or application of 
different chemical substances18,102,115,209,342 like hypertonic saline, serotonin, bradykinin, 
capsaicin cream or nerve-growth factor, and some of which involve endogenous production of 
noxious substances through ischemia or over-exertion9,98,104,272,325. Each model has 
advantages and disadvantages in terms of administration complexity, location and/or tissue 
specificity, duration of pain induced, and concurrent elicitation of clinical features. In the present 
work, the desire was to mimic an episode of acute LBP, thus the model needed to produce 
deep-tissue pain, preferably exacerbated by movement, that could be maintained for several 
days. For this reason, delayed onset muscle soreness/pain (DOMS) as is induced by 
performing unaccustomed eccentric exercise to fatigue, was the obvious choice. Prior studies 
have used this approach to produce DOMS in the lower back162,180 and have shown it to mimic 
mild LBP producing some degree of LBP-related disability30. This was employed in Study I of 




Study I design 
with fatiguing 
exercise 
performed on Day 
0 aiming to induce 
experimental LBP 
(shown as yellow 
curve) by the 
session on Day 2 
and full recovery 
by Day 7 
 
 
2.1.3. USING RECURRENCE AS A PAIN MODEL 
Another way to probe temporal relations between LBP and pain sensitivity, or at least to probe 
the impact of pain presence on measures of pain sensitivity, is to select patients who present 
with defined painful and pain-free periods. This allows one to study the effect of clinical pain 
within-individuals over time. Naturally, recurrent LBP patients represent a perfect population for 
this type of investigation, with these patients commonly experiencing pain lasting for several 
days to weeks, followed by weeks to months of near-complete recovery. Several challenges 
with this approach are apparent; namely the difficulty of standardising testing intervals due to 
varying painful episode lengths, the inability to randomise painful and pain-free sessions due 
to the unpredictable nature of recurrent pain, and the general heterogeneity of LBP conditions. 
However, in part these challenges can be overcome by highly selective recruitment of patients 
with estimable pain episode trajectory and the use of age- and gender-matched control 
participants over a comparable time interval. As such, this study design is clearly advantageous 
in allowing for both within- and between-individual comparisons to determine the effect of an 
authentic clinical pain experience on measures of pain sensitivity. This approach was used in 
Study II of the current work (Fig 2-2, summarised in Appendix A).  
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Figure 2-2 Illustration of 
Study II design with 
control participants 
(top) compared to 
RLBP patients (bottom) 
during a painful 
episode (Day 0, pain 
represented by orange 
curve) and once 




2.1.4. MODULATING CHRONIC PAIN 
Another approach to investigating temporal relationships between LBP and pain sensitivity is 
to take a relatively stable chronic pain condition and attempt to modulate it. This would allow 
one to track changes in both pain and hypersensitivity simultaneously over time, and thus 
gain insight into their possible co-variation. As such, in Study III of the current work, CLBP 
patients were recruited and tracked over an extended period during the application of an 
active and a sham high-definition transcranial direct current stimulation (HD-tDCS) paradigm, 
aimed at improving anti-nociceptive pain mechanisms and thus potentially reducing pain. By 
using a crossover design, sample size requirements are minimised and changes in clinical 
and pain sensitivity measures between conditions and over time can be compared without the 




Study III with 
CLBP patients  
receiving both 
Active and Sham 
tDCS targeted to 
the PFC/ACC, 
with the aim to 
improve pain 
modulation (Day 
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The present thesis details four approaches to understanding the effect of LBP on measures of 
pain sensitivity, including: meta-analysis of existing cross-sectional data, induction of 
experimental LBP in pain-free individuals, comparing painful and pain-free periods in RLBP 
patients and modulating CLBP symptomatology. In order to have an overview of these 
approaches and see the broader effect of present LBP on clinical and pain sensitivity measures 
across the experimental studies (I-III), throughout the thesis, a representative painful and pain-
free or pain-reduced session has been selected for each LBP group. This is summarised in 
Figure 2-4, where an overall visual depiction of the different experimental timelines is shown, 
and the representative sessions included in the primary outcome analyses throughout the 
remainder of the thesis are highlighted.  
 
 
Figure 2-4 Study designs, split into participant groups, are overlayed to indicate temporal 
differences in painful and pain-free (Studies I-II) or pain-reduced (Study III) assessment sessions, 
as used for comparison throughout the present thesis. Note: Coloured curves represent pain profiles, 
coloured dots represent painful sessions, black dots indicate pain-free sessions, grey dots with dashed 
borders indicate sessions in which a full assessment was conducted, for which data can be seen in the 
individual study manuscripts and/or their supplementary materials.  
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CHAPTER 3. INDIVIDUAL & CLINICAL 
CHARACTERISTICS AND CONFOUNDERS 
To accurately interpret the findings from the present experimental studies, it is imperative to 
understand both the characteristics of the included participants and the features of the LBP 
conditions being assessed. Hence, demographic information was collected from all included 
participants, and various measures were used to capture the severity, distribution and type of 
pain, as well as the impact it had on participants, both in terms of disability and care-seeking 
behaviour, among those with LBP conditions. As several contextual factors have also been 
shown to influence both LBP and pain sensitivity, these potential confounders were captured 
using various questionnaires. This chapter presents an overview of these characteristics.   
 
3.1. GENERAL SAMPLE CHARACTERISTICS 
3.1.1. PARTICIPANT SCREENING  
To be able to draw conclusions about the relationship between pain sensitivity and LBP, it is 
essential to select suitable experimental participants both with and without clinical pain. 
Although seemingly simple, the quality assessment of the Systematic Review highlighted that 
many prior cross-sectional studies did not use adequate screening procedures to exclude 
individuals with prior histories of LBP in control groups, nor provide complete definitions or 
characterisations of LBP on testing in LBP groups. For this reason, strict inclusion and 
exclusion criteria were used in all present experimental studies (I-III, Table 3-1). All criteria were 
screened on recruitment and reconfirmed via clinical anamnesis and physical exam in the first 
session. While these strict criteria aid the strength of conclusions on effects of pain presence 
for the studied populations, they do notably also introduce potential generalisability issues.  
Table 3-1 Inclusion and exclusion criteria for Studies I-III 
 Study I & Study II (Healthy) Study II (Recurrent LBP) Study III (Chronic LBP) 
General Aged 18-60 years; Able to read, write and understand English 
Location No history of significant LBP 
No history of chronic or 
recurrent pain conditions  
No recent acute lower limb pain  
Primary complaint of pain in low back (defined as between 
inferior costal margin and inferior gluteal fold) 
No history of other chronic or recurrent pain conditions 
No recent acute lower limb pain  
Duration No LBP lasting >24 hours not 
due to unaccustomed exercise 
No other injuries past 6 months 
LBP for >24 hours, <3 months 
Present in first session but 
expected to resolve <4 weeks  
>1 previous episode past year 
LBP for >3 months 
Continuously present (>3 
days/week) since onset 
Present in first session 
Intensity VAS = 0 VAS>1/10 on testing VAS>3/10 on average  
Impact No activity limitation Pain sufficient to impact daily activity 
Other  No neurological, musculoskeletal, cardiorespiratory or mental disorders; Not currently or planning to 
be pregnant; No substance abuse; No regular medication use (Inclusive analgesics, exclusive 
contraceptives); No analgesic use in 24 hours prior to testing; Not currently seeking treatment for 
any condition (Inclusive LBP) 
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3.1.2. DEMOGRAPHIC DETAILS 
Much of the literature reports variation in pain sensitivity measures and incidence of pain 
conditions based on inherent individual factors, such as age, gender and body mass index. 
Typically advancing age173,215, female gender276,289,299 and high BMI124,311,360 are associated 
with increased rates of pain complaints and altered pain sensitivity. As a result, it seemed 
pertinent to record and report these factors in all studies and to try to control for them in Study 
II as potential between-group confounders (Table 3-2). It is noteworthy, however, that in the 
present experimental studies all participants were relatively young (18-45 years). Perhaps even 
younger than expected for typical RLBP and/or CLBP patient populations, which may suggest 
this sample represents an earlier stage of LBP with milder symptomatology than much of the 
existing literature. As well, despite slightly higher average weight in LBP groups, BMI was within 
normal limits in most participants with no statistical group differences observed (Appendix C).  
Table 3-2 Demographic Characteristics of All Participants in Experimental Studies 
 Study I (Healthy) Study II (Healthy) Study II (RLBP) Study III (CLBP) 
Recruited & tested 30 30 30 12 
Age 24.5  4.5 27.3  5.5 27.3  5.4 28.6  5.9 
Height 173.8  11.8 170.9  9.9 175.6  11.2 172.6  9.4 
Weight 72.1  15.6 68.1  12.3 75.2  16.3 75.4  16.1 
Gender 14 men: 16 women 16 men: 14 women 16 men: 14 women 3 men: 9 women 
Included in main 
analysis (reason 
for exclusions) 
24 (excl. 6 due to 
no pain on Day-2) 
30 26 (1 drop-out, 
excl. 3 with 
ongoing pain at 
Day-28) 
12 (1 missing final 
follow-up session) 
 
3.2. LOW BACK PAIN CHARACTERISTICS 
3.2.1. PAIN RATINGS 
The International Association for the Study of Pain (IASP) definition of pain states that it is both 
a “sensory and emotional experience…” As such, many have used subscales of intensity and 
unpleasantness, to capture and quantify these distinct aspects of the pain experience. In the 
present work, participants were instructed using a sound analogy adapted from Price258, in 
which pain intensity is analogous with volume, whereas unpleasantness becomes dependent 
on other personal or preferential and evaluative factors. These features were evaluated on two 
separate Visual Analogue Scales (VAS) anchored at 0cm as ‘no pain/unpleasantness’ and 
10cm as the ‘worst pain/most unpleasant sensation imaginable’. The VAS as a numerically 
anchored ratio scale was initially validated in both healthy and chronic pain populations45,256,258, 
and has since been used extensively to quickly capture pain severity. In Studies I-III, current 
pain intensity and unpleasantness ratings were recorded at every assessment session, while 
an overall pain severity score was collected in home diary measures. Interestingly, when 
comparing LBP rating data across studies (Appendix C), mean current pain intensity ratings 
were surprisingly similar, at around 2.5-3/10, though considerable inter- and intra-individual 
variability in LBP over time was observed in pain diaries (Studies I-III, Figure 3-1, Table 3-3). 
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3.2.2. PAIN DISTRIBUTION 
Body schematics from the Navigate Pain application (Algance Solutions & Aalborg University) 
were used to capture the spatial extent of LBP. Participants were instructed to draw in different 
ways depending on the study purpose. In study I, participants were instructed to draw the areas 
in which they felt pain or soreness during tasks involving back muscle activity, such as forward 
bending and lifting (as DOMS rarely causes resting pain). In study II, RLBP patients were asked 
to draw their pain area both relaxed at rest and during provocative back movement. In study 
III, CLBP patients were asked to draw their pain area sitting at rest in a chair during each 
session. Due to these slight variations in instruction, direct comparison of pain areas between 
studies is not possible, though overlays of individual participants’ pain areas for each study are 
shown in Figure 3-1. From these diagrams, it is readily apparent that pain in the DOMS model 
extended beyond the lower back, with some participants also reporting pain in e.g. the 
hamstrings and calves, which was rarely the case in the clinical populations. This is 
unsurprising given that the movement performed to fatigue also places a large amount of strain 
on the gluteal and posterior leg muscles. On the contrary, especially female participants in the 
RLBP and CLBP groups commonly drew pain extending upward into the shoulders and neck, 
which may be a protective consequence of clinical LBP, due to stiffening of the trunk in order 
to reduce movement128.  
 
Figure 3-1 Pain diaries from each experimental study (I-III) illustrating individual participant 
reports (grey) and group mean ( SEM, black) data over the study period, mean (+SEM) pain 
intensity and unpleasantness ratings for each LBP group in a selected painful and pain-free 
session, and overlays of all participant’s pain distributions from the first painful session for each 
LBP group (colour-coded). Note: Painful session data is from Study I Day 2, Study II Day 0, and Study 
III Day 1; non-painful or pain-reduced data is from Study I Day 1, Study II Day 28, and Study III Day 24. 
Not all participants represented at all time-points due to missing or partially completed diaries.  
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3.2.3. PAIN QUALITY  
As pain is a highly individual and thus variable experience, in all studies, the 72-word table of 
the McGill Pain Questionnaire was used to record a depiction of each individual’s pain. Among 
these words are descriptors of sensory (e.g. pulsing, hot, sharp), affective (e.g. tiring, terrifying), 
and evaluative features (e.g. annoying). Developed in 1975, the McGill Pain questionnaire199 
has been widely used both to capture pain types among different patient groups and to monitor 
changes in pain in response to intervention. In the present work, overall scores were similar 
between clinical LBP groups, though much lower in experimental LBP and generally highly 
variable between individuals. Interestingly, ‘annoying’ came out as one of the most common 
descriptors in all LBP conditions, despite being from the evaluative subdomain which is typically 
more associated with persistent pain states270. Other common descriptors across LBP 
conditions were primarily for sensory features of pain (e.g. tight, pressing), with only CLBP 
patients commonly using affective descriptors (i.e. tiring, Table 3-3).  
Pain quality assessment is thought to be able to give an indication of potential underlying 
mechanisms. As such, in 2006 the Pain-DETECT questionnaire83 was developed as a quick 
screening tool to identify neuropathic pain components among LBP patients. Based on the 
initial validation, this questionnaire was deemed to be reliable with high specificity, sensitivity, 
and positive predictive value in identifying these features, and was hence quickly adopted in 
further research. In studies II and III, the Pain-DETECT questionnaire was used to characterise 
neuropathic features among patients with RLBP and CLBP. The original cut-off values were 
used to interpret Pain-DETECT responses, with scores above or equal to 19 indicating 
predominantly neuropathic pain features and scores below or equal to 12 indicating 
predominantly nociceptive components. In the present studies, most participants had scores 
suggesting primarily nociceptive components, with only two RLBP patients and one CLBP 
patient scoring above the threshold to indicate presence of neuropathic features (Table 3-3).  
3.2.4. PAIN-RELATED DISABILITY 
The Roland-Morris Disability Questionnaire was originally developed and deemed reliable to 
assess LBP-related disability in 1983280. It consists of 24 statements that describe daily 
activities or functions that may be negatively impacted by LBP. Generally, participants included 
in the present work demonstrated very low levels of disability on this scale, suggesting they 
may represent a mild patient group. Disability was, however, slightly higher in RLBP patients 
than that provoked by the DOMS model, and slightly higher again in CLBP patients than RLBP 
patients (Table 3-3, Appendix C). It should be noted that it was intended only to include LBP 
patients who did not have comorbidities or concurrent pain conditions in other body regions, 
which may explain why the present sample were only mildly disabled by their pain.  
The STarT-Back Screening Questionnaire (Short form) was developed as a prognostic 
screening tool to be used in primary care decision-making126. It has since had cut-off scores 
validated in external LBP populations126 and has shown similar utility to other prognostic 
screening questionnaires127. In the present work, this measure indicated mild trajectories 
among the included LBP populations with majority low risk categorisations (Table 3-3).  
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3.2.5. CARE-SEEKING BEHAVIOURS 
Participants with clinical LBP were asked a range of typical medical history questions regarding 
aggravating and easing factors, along with prior care sought (Table 3-3). All patients displayed 
mechanical aggravation of LBP on either specific movements or prolonged positioning, and 
most reported improvement with rest. Every participant with CLBP had sought some form of 
care previously (either medical or allied health), whereas only half of RLBP patients had done 
so. Further, a greater proportion of CLBP patients had obtained medical imaging of the spine 
(typically with plain x-ray or MRI) and trialled analgesic medication than RLBP patients. 
Although quality of life was not assessed in the current work, these reports naturally suggest a 
greater negative impact of pain and higher medicalisation of CLBP than RLBP.  
Table 3-3 Clinical Characterisation of Low Back Pain in Experimental Studies based on Patient History 
and Questionnaire data collected in First Painful Session 
  Study I (DOMS) 
Day 2 (n = 24) 
Study II (RLBP) 
Day 0 (n = 26) 
Study III (CLBP) 










 Pain Intensity (VAS, cm): 
- Current at time of testing 
- Maximum* 
 
2.9  1.8 
4.1  2.0 
 
2.7  1.5 
5.8  2.2 
 
2.6  2.0 
3.8  1.3 
Pain Unpleasantness (VAS, cm): 
- Current at time of testing 
- Maximum* 
 
2.9  2.4 
- 
 
4.0  1.8 
6.6  2.0 
 
3.2  2.3 

















- Current episode duration 
- Age at initial onset (years) 
 
3.3  1.2 days 
NA 
 
12.3  15.9# days 
19.7  5.4 
 
5.3  2.6#¤ years 
23.3  6.6 
Aggravating Factors: 















































STarT-Back Screening Tool: 
- Total Score (/9)  
- Categorisation (Low/Med/High) 
 
1 (2) 
23 / 1 / 0 
 
2 (2) 
22 / 4 / 0 
 
3 (2) 
7 / 4 / 1 
McGill Pain Quality Descriptors: 
- Total score 
- Most common descriptors (n) 
 
9.1  6.4 
Annoying (13), sore 
(11), tight (9) 
 
20.2  10.3# 
Annoying (13), sharp / 
shooting / pressing (10) 
 
18.2  8.7# 
Tight (7), annoying / 
tiring (6) 
Pain-DETECT: 
- Total score 





15 / 9 / 2 
 
9 (2.5) 
10 / 1 / 1 
Roland-Morris Disability 
Questionnaire: 
1.5 (1.5) 3.5 (3.5) 5 (3) 
*DOMS and RLBP current episode, CLBP in past 24 hours; Difference between-groups to DOMS# or RLBP¤ (P<0.05)  
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3.3. CAPTURING CONFOUNDERS 
All observations of psychophysical outcomes, including pain sensitivity measures, come with a 
range of possible confounding influences. It is well-known that various factors, such as 
sleep77,116,143,269,296, hormonal cycles117,273,277,350, mood72,339, anxiety96,202,331, pain 
catastrophizing353 and physical activity levels118,216,275, can impact an individual’s experience of 
pain. As such, it was not the intention of the present thesis to explore neither the effect of these 
factors on clinical pain, nor their association to pain sensitivity, hence the individual studies are 
not appropriately powered for this type of analysis. Instead, these factors were captured 
primarily to allow for better attribution of observed pain sensitivity findings to changes in LBP 
condition; i.e. to exclude the possibility that differences in pain sensitivity measures between 
sessions were due to changes in these factors and not to pain. A brief summary of relevant 
findings is provided here for context, but more detailed descriptions of the rationale for 
assessing these factors, the specific measures used, an overview of the validity of those 
measures and the general findings are provided in Appendix B. In addition, details of analyses 
conducted between studies are provided in Appendix C.  
Generally, no differences were noted for mood between sessions or groups, and females were 
approximately randomly distributed between menstrual phases in each session. For CLBP 
patients, slightly shorter sleep duration was reported prior to the reduced pain session (Table 
3-4) but no differences were noted overall between groups. Although no significant group 
differences were noted in number of nightly awakenings, a greater proportion of RLBP patients 
reported at least one awakening (Table 3-4). Sleep disturbance is commonly reported among 
LBP populations116,143,192 and may even be a risk factor for LBP development341, though 
objective sleep measures (e.g. actigraphy) have shown less clear differences233,335. 
For RLBP patients (Study II), positive affect, state anxiety and pain catastrophizing were slightly 
higher during the first painful session compared to when pain-free, though not different to 
control participants in either session (Table 3-4). On the contrary, for experimental LBP (Study 
I) pain catastrophizing scores were lower during the painful session compared to when pain-
free (Table 3-4). As pain catastrophizing scores were not different between controls and the 
different clinical LBP populations overall, this contrasting finding between LBP conditions might 
indicate that participants, who had temporary pain present at the time of testing, related 
cognitions directly to that specific pain (i.e. experimental or recurrent LBP) rather than to pain 
in general, as the scale instructs. These findings would then aptly reflect that RLBP episodes 
are unpredictable and threatening by nature, whereas DOMS is familiar (to most) and thus of 
predictable severity, provocation (i.e. on movement), and time course.  
Of note, healthy participants in Studies I and II tended to report lower physical activity levels 
than RLBP and CLBP patients from Studies II & III, and RLBP patients had higher mean activity 
prior to the painful session than the pain-free session (Table 3-4). This could reflect two 
scenarios: firstly, it could indicate that LBP was present and/or exacerbated by periods of high 
physical activity and resolved with reductions in this factor. However, this seems unlikely given 
most patients did not report exercise or activity as an aggravating factor (on the contrary many 
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reported prolonged static postures to be most aggravating), and when interviewing patients 
very few described undertaking laborious work or frequent exercise training. Alternatively, this 
could be an overestimation reflective of perceptual differences about effort when in pain versus 
not, whereby patients categorise more activities as more vigorous when in pain. The latter 
would be consistent with prior studies showing LBP patients to be more inaccurate at reporting 
physical behaviour286, and showing associations between subjective, but not objective, physical 
activity levels and musculoskeletal pain220.   
Table 3-4 Baseline Questionnaire Characterisation of Participants across all experimental studies from 
one painful and one pain-free (or less painful) session presented as mean  standard deviation or 
median (interquartile range).  
Note: NP = no pain, LP = less pain, NA = not assessed. *denotes significant between-sessions difference, #denotes 
difference from DOMS group, details of outcome measures provided in Appendix B and analysis in Appendix C. 
 
  Study I (Healthy) Study II (Healthy) Study II (RLBP) Study III (CLBP) 
  N = 24 N = 30 N = 26 N = 12 






















Sleep time (Hours 
slept on night prior 
to testing) 
6.71.4 7.21.0 7.30.9 6.90.8 7.51.2 7.31.6 6.71.2 7.71.1* 
Awakenings 
(Number of nightly 
awakenings on night 























Face scale (Mood at 
time of testing) 
3 (4) 2.5 (3) 3 (2.75) 4 (4) 4 (3.75) 3.5 (3.75) 3.5 (4.25) 5.5 (4) 
Faces scale (Mood 
week prior to test 
session) 
3.5 (4) 3 (4) 4 (4) 3 (5) 3.5 (4.75) 3.5 (4.75) 5 (3.5) 4.5 (3.25) 
PANAS (Positive 
affect score) 
NA NA 30.16.4 29.17.2 30.85.9* 27.77.7 26.57.8 22.810.4 
PANAS (Negative 
affect score) 
NA NA 12.7  3.2 13.0  3.2 14.2  4.9 12.9  2.8 12.9  3.1 11.9  2.5 








STAI (State anxiety 
score) 
NA NA 30.87.9 32.49.6 34.28.6* 31.37.2 34.98.4 39.711.2 
STAI (Trait anxiety 
score) 
NA NA 36.68.3 36.27.9 37.98.2 37.38.7 41.26.1 41.67.8 
PCS (Total score) 8.87.3 13.58.8* 12.98.6 13.59.6 
15.5 
9.0*# 
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Clinical characteristics, including pain intensity, unpleasantness, duration, related disability, 
quality, and distribution, were captured among both experimental and clinical LBP groups using 
validated self-report scales and applications. All LBP groups reported similar pain intensity and 
unpleasantness within the painful session, with pain mostly localised to the lower back region. 
Pain duration was obviously different between LBP conditions, as would be expected from 
inclusion requirements, and pain quality scores were higher for clinical LBP groups. Disability 
levels were generally very low but followed the expected trend with experimental LBP less 
impactful than RLBP, and CLBP patients showing most impact. Similarly, care-seeking 
behaviour, along with prior imaging and analgesic use, was higher in CLBP than RLBP patients.  
Various factors could potentially contribute to the differences seen in the primary outcomes of 
this thesis. Individual characteristics, including age, gender, BMI, sleep, menstruation, mood, 
anxiety, pain catastrophizing, and physical activity, were captured in the present work using 
common validated self-report measures. All participants, including patients with LBP, were 
young with predominantly normal BMI. Most factors did not differ significantly between 
experimental groups, suggesting they are unlikely to confound between-group findings 
presented throughout the thesis. Small differences were noted, between sessions for the RLBP 
group, in positive affect, state anxiety and pain-related catastrophizing, indicating that this may 
play some role in identified between-session differences, which is discussed where relevant in 
subsequent chapters.
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CHAPTER 4. LOCAL AND WIDESPREAD 
PRESSURE PAIN SENSITIVITY 
To assess whether experimental LBP (Study I), RLBP (Study II) and CLBP (Study III) presence 
was associated with local and widespread hypersensitivity to pressure, the present work 
assessed pressure pain thresholds using both handheld and computerised-cuff methods at an 
array of body locations. This chapter discusses conceptual aspects of pain threshold 
assessment, methodological considerations, and findings from the experimental studies (I-III) 
for these measures.  
4.1. ASSESSING BASAL PRESSURE PAIN SENSITIVITY 
Pain thresholds have long been used as a probe to investigate sensitivity to sensory stimuli, 
allowing for comparison between body sites and tissues, between individuals and over time in 
response to interventions. As early as 1959 researchers were questioning whether such pain 
thresholds would ever be of clinical value218. Despite this, investigations have continued for 
more than six decades now across a broad range of stimuli and are beginning to show 
potential11,92. In chronic pain populations, reduced pain thresholds at both local and remote 
sites to the painful region, i.e. local and widespread pressure hypersensitivity, are commonly 
demonstrated in cross-sectional studies11. In patients with LBP190,235 and other painful 
conditions42,300, these alterations have generally been considered consequential to ongoing 
pain, though there is also evidence that high pain sensitivity may have predictive110,291,348 and 
prognostic value92 in some circumstances.  
With regard to stimulus type, mechanical stimuli have been of particular interest in LBP 
populations, with pressure hypersensitivity consistently demonstrated in comparison to pain-
free populations at both local and remote sites62. In fact, in this thesis, the focus has been 
exclusively on sensitivity to painful pressure for several reasons. Firstly, this was deemed to be 
the most relevant to LBP, as both handheld and cuff pressure algometry can better assess 
sensitivity of the deep musculoskeletal structures78,188 thought to be involved in pain generation. 
Especially cuff compression has been shown to produce considerable strain in deep tissues, 
and evoke pain even in the absence of cutaneous nociception255. Pressure pain thresholds 
have also previously been reported to have high discriminative ability for identifying 
hypersensitivity in CLBP patients221.   
4.1.1. PAIN DETECTION VERSUS PAIN TOLERANCE 
Pain detection thresholds, in this thesis, were defined as the lowest intensity at which a stimulus 
was first perceived to be painful. Pain tolerance thresholds, on the contrary, were defined as 
the intensity at which the participant could no longer tolerate further increases in stimulus 
intensity.  These perceptual thresholds are well-known to be influenced by a range of individual 
state and trait factors149,194,198. They also intuitively seem to represent different constructs, 
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whereby detection thresholds may be more reflective of nociception and sensory factors, and 
tolerance thresholds more reflective of cognitive and evaluative processes87. In the present 
work, detection thresholds were assessed using handheld algometry bilaterally at five sites and 
using cuff algometry bilaterally on the lower legs. Tolerance thresholds were then only 
assessed with cuff algometry on the lower legs.  
4.1.2. METHODOLOGICAL CONSIDERATIONS 
When assessing pressure pain sensitivity, the main methodological considerations are body 
site and thus underlying tissues assessed, application characteristics (such as rate of stimulus 
increase, contact area, manual versus automated application), and instructions to participants. 
In the present work these features were standardised, as per the overview in Table 4-1, across 
all experimental studies. Such parameters were selected to be consistent with prior work105. 
Table 4-1 Overview of pressure pain sensitivity methods used in all studies 













Extensor Carpi Radialis Brevis 
(ECR): 3cm distal to lateral 
epicondyle; Upper Trapezius 
(UT): halfway between 
acromion & 7th cervical 
spinous process; L1/5: 3.5cm 
lateral to 1st/5th lumbar spinous 
processes; Gastrocnemius 
(GAS): halfway between 








two (Study III) or 
three (Study I-II) 
times. 
Press the stop button as 
soon as the pressure first 









(NociTech & AAU, 
Aalborg, 
Denmark) paired 
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Cuffs positioned bilaterally 
over the widest portion of each 
lower leg, roughly 5cm below 
the tibial tuberosity. Sensitivity 
assessed separately for each 
leg. 
Increased at 
1kPa/s to a 
maximum of 
100kPa (device 




As soon as the pressure 
becomes uncomfortable or 
painful, start sliding the 
electronic Visual Analogue 
Scale (eVAS) dial to rate 





When the pressure is so 
painful that you cannot 
tolerate anymore, press 







As above but only assessed 
on dominant leg. 
Increased at 
100kPa/s to cPTT 
pressure, 
maintained for 1s, 
then released for 
10s, repeated 
three times. 
Immediately following each 
stimulus rate how painful it 
was by sliding the eVAS 
up, then return it to zero. 
 
4.1.3. VALIDITY & RELIABILITY OF ASSESSMENT 
Pressure pain sensitivity was of interest due to the ability to assess deep structures. Combined 
computer modelling with experimental and MRI approaches have shown handheld78 and 
especially cuff188 algometry to increase strain in muscle and deep tissues and cause pain, even 
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when cutaneous nociceptive fibers are anaesthetized153,255, suggesting that these modalities 
are valid to assess deep tissue sensitivity.  
In the supplementary material of Study II, the reliability of all measures was assessed within- 
and between-sessions where possible. Control participants from Study II provide a clean 
estimate of test-retest reliability for the measures included in the present thesis, as precisely 
the same methodology was repeated in each session with no intermediary provocations and 
no expected change in condition. Results of this reliability analysis can be seen in Table 4-2 
(adapted from Study II supplementary material). Generally, pressure pain thresholds (PPTs), 
cuff detection and tolerance thresholds, and supra-threshold ratings were highly reliable 
(ICC>0.9) within a session. Reliability was lower between-sessions, but still high (ICC>0.8) for 
PPTs and cuff tolerance, and moderate (ICC>0.6) for cuff detection thresholds and supra-
threshold ratings (Table 4-2). This is consistent with prior work in which both handheld20,228,347 
and cuff103,105 pressure algometry have shown very good reliability.  
Table 4-2 Intra-class correlation coefficients (ICC3,k) with 95% confidence intervals [95%CI] for handheld 
and cuff pressure pain thresholds within and between sessions for control participants in Study II 
 Within-session 1  Within-session 2 Between-sessions 


























































4.2. PRESSURE HYPERSENSITIVITY IN LOW BACK PAIN 
4.2.1. HANDHELD PRESSURE ALGOMETRY 
Pressure pain thresholds were very clearly affected by the presence of pain in the region being 
tested (L1 and L5 sites), indicating that local hypersensitivity to pressure was a feature of both 
experimental and clinical LBP (Figure 4-1). This was true both when PPTs were compared 
between-groups to an independent control population (Study II) and when compared within-
groups to the same individuals when not in pain (Study I and II). Albeit not the main purpose of 
Study III, when looking at data from CLBP patients, the same trend is observed with higher 
PPTs in the least than most painful session. Further, on re-analysis across all studies, PPTs, 
especially at the L1 site, were reduced when LBP was present across all experimental studies 
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(Study I-III, Fig 4-1, Appendix C). No differences were noted, however, between LBP groups. 
This fits with much of the existing literature on the topic showing lowered PPTs, likely reflective 
of peripheral sensitisation, to be maintained by ongoing nociception302,309 and to fluctuate with 
clinical pain intensity62,190,235,300. Thus, local pressure hypersensitivity observed here seems 
merely consequential to experimental and clinical LBP.  
Intriguingly, remote assessment sites were also impacted by the presence of LBP, with reduced 
PPTs demonstrated both between RLBP and control participants (Study II) and within-groups 
between painful and pain-free sessions in participants with DOMS (Study I) and RLBP (Study 
II). This was also reflected when data were reanalysed across all studies (Figure 4-1, Appendix 
C), with increased PPTs observed during pain-free sessions for DOMS and CLBP participants, 
and reduced PPTs during painful sessions compared to controls for at least one external site 
in all LBP groups. For CLBP patients, there appears to be no change in remote sites between 
more and less painful sessions, though given the design of Study III, it is difficult to attribute 
changes or lack thereof to pain alone.  
 
Figure 4-1 Mean (+SEM) pressure pain thresholds across all sites for all experimental studies 
from a representative session with low back pain present and absent. Note: *denotes within-group 
difference between-sessions, #denotes difference from controls in painful session, ¤denotes difference 
from controls in pain-free/pain-reduced session. Details of analysis are shown in Appendix C.    
 
The Systematic Review conducted as part of this thesis did not include PPTs as an outcome. 
However, a recent meta-analysis62 showed overall enhanced sensitivity to pressure at local 
sites (gluteal), regionally-related sites (scapula), and some remote sites (leg and arm, though 
not hand) in patients with LBP, suggesting pressure pain hypersensitivity to be present at both 
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local and distant sites. It should be noted though, that the magnitude of difference was variable 
across sites like that observed here, and conclusions from individual studies were often 
contradictory possibly due to differences in sample characteristics. Although widespread 
hyperalgesia has been reported among some LBP populations6,205,221,236, it is not commonly 
reported in experimental pain models like DOMS. In this case, it is possible that widespread 
differences instead result from: peripheral sensitisation due to repeated testing over relatively 
short intervals228,301, recruitment of additional muscles beyond the agonists at sufficient 
intensities to cause discrete muscle soreness, low-grade systemic inflammatory responses 
elicited by the intense and exhausting exercise315, or perceptual alterations due to present pain 
state; though this requires further investigation.  
4.2.2. CUFF PRESSURE ALGOMETRY 
Cuff thresholds were not consistently altered by LBP presence. As shown in Figure 4-2 below, 
cPDT was significantly higher in RLBP patients when pain-free than when in pain (Study II). 
However, cPTT was unchanged by RLBP presence (Study II), and neither cPDT nor cPTT were 
altered by the presence of experimental LBP (Study I). In CLBP patients, both cPDT and cPTT 
were clearly increased in the less painful session, but due to the study design and repeated 
stimulus exposure (see Chapter 7, Figure 7-3) this cannot be solely attributed to changes in 
LBP severity and may more so reflect temporal habituation. On reanalysis of cPDTs and cPTTs 
across studies, no differences were observed between LBP groups and controls regardless of 
LBP presence (Appendix C).  
 
Figure 4-2 Mean (+SEM) Cuff pain detection (cPDT) and tolerance (cPTT) thresholds for the 
dominant and non-dominant legs of participants in each of the experimental studies. Note: Data 
is presented from one painful and one pain-free (Studies I & II) or pain-reduced (Study III) session. 
*denotes a significant difference between-session within the RLBP or CLBP group (P<0.05) 
 
Cuff compression was theorised to provide a better characterisation of pain sensitivity in more 
relevant deeper structures than even handheld algometry, hence it is odd that few differences 
were observed. However, this was also the case for handheld algometry at the gastrocnemius 
site. The lower leg was deemed to be the best location for the cuffs as it: is easy to access, 
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allows for concurrent intensity rating with the upper limbs, provides reliable results while 
reducing ceiling effects due to the cuff device’s safety limit178, and is innervated by spinal levels 
that also innervate some regions of the lower back (L4-S2)219. However, deep tissue pressure 
hypersensitivity may remain localised, especially in the experimental LBP condition, making 
this remote assessment site inadequate to capture changes in muscle sensitivity.  
In terms of tolerance thresholds, it is interesting that no differences were observed with regard 
to present LBP state (with the exception of in CLBP patients where effects are more likely time 
and/or exposure related) nor on reanalysis between groups. Generally, cuff pain tolerance 
thresholds have been less well studied among LBP populations. Prior studies using handheld 
algometry in CLBP patients have demonstrated lowered tolerance thresholds over the lower 
back2,221 and other344 assessment sites, but a single study using cuff algometry observed 
reduced tolerance only in those with severe CLBP100. The lack of findings here may, in part, be 
due to the remote assessment site or due to the mild symptomatology of the patients included.  
4.2.3. SUPRA-THRESHOLD PRESSURE STIMULATION 
In all studies, pain intensity ratings of three brief stimuli applied at cPTT intensity were collected. 
This was primarily as a manipulation check to make sure that this pressure level and thus TSP 
stimuli were considered painful. Nevertheless, as tolerance threshold assessment was based 
on a button press and not anchored to the eVAS ratings (i.e. participants did not need to reach 
10/10 prior to stopping), it is interesting to look at these results alongside those ratings at 
tolerance. On reanalysis across studies, ratings of suprathreshold stimuli were lower overall in 
the pain-free or pain-reduced sessions, which seems to be an effect driven by the clinical LBP 
groups (Figure 4-3, Appendix C). As neither pressure nor perceived pain intensity at cPTT was 
different between sessions in most cases, this would imply that participant’s appraisal of this 
stimulus may have changed144. This could be due to decreases in both stimulus and contextual 
novelty and hence increased predictability which is known to interfere with pain perception247.  
 
Figure 4-3 Mean (+SEM) pain intensity ratings at cPTT on threshold assessment (left) and of 
three 1-second stimuli at cPTT intensity (STR, right) in each of the studied populations for one 
painful and one pain-free or pain-reduced session. Note: *denotes significant difference between-
sessions within RLBP group (P<0.05). Details of between-studies analysis presented in Appendix C. 
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4.3. SUMMARY 
The present work evaluated pressure pain sensitivity using reliable methods at standardised 
assessment sites across all experimental studies. Local hypersensitivity to pressure was clearly 
present in all LBP populations compared to pain-free controls, but this largely resolved when 
LBP was not present. Widespread reductions in PPTs were also noted in both experimental 
and clinical LBP conditions, though reasons for this apparent widespread pressure 
hypersensitivity may differ between the DOMS model and clinical LBP. In experimental and 
RLBP, these widespread changes were not present when pain-free, but no significant 
differences between sessions were noted in CLBP patients. Pain detection and tolerance 
thresholds, along with ratings of supra-threshold stimuli, were also evaluated in all experimental 
groups using valid and reliable user-independent cuff algometry. This was theorised to provide 
better characterisation of deep tissue sensitivity but did not capture many differences between 
groups or sessions, with the exception of higher pain detection thresholds and lower supra-
threshold ratings shown in Study II within RLBP patients when pain-free, and higher pain 
tolerance thresholds in CLBP patients when pain was reduced. The lack of between-group 
findings for cuff algometry was attributed to the remote assessment site and mild 
symptomatology of included LBP patients. Overall, the present findings would suggest pressure 
hypersensitivity to be a consequence of ongoing LBP.
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CHAPTER 5. PRO-NOCICEPTIVE 
ASCENDING PATHWAYS 
This chapter describes the conceptual underpinnings of dorsal horn wind-up, methodological 
considerations of TSP assessment in humans, and discusses findings from the present work 
on the impact of LBP on this measure (Systematic Review, and Studies I-III).   
5.1. ASSESSING ASCENDING FACILITATORY PATHWAYS 
5.1.1. MECHANISMS BEHIND TEMPORAL SUMMATION OF PAIN 
Temporal summation of pain (TSP) is thought to measure 
at least the initial phase of ‘wind-up’; a frequency-
dependent C-fibre mediated enhancement of neuronal 
excitability in response to repeated noxious stimulation, 
first described in 1965200,268. Mechanistically, noxious 
stimulation at 0.5-2Hz297 leads to release of various 
peptides from C-fibres, producing prolonged membrane 
depolarisation, removal of magnesium ion plugs, and 
activation of NMDA receptor channels in the dorsal horn64. 
This means that the same peripheral noxious stimuli and 
C-fibre activation will result in enhanced and prolonged 
activity in ascending nociceptive pathways; a mechanism 
which can potentially explain disparities between objective 
injury and perceived pain358. As direct recordings from 
dorsal horn neurones, like those performed in animals, are 
not possible in humans, TSP measures instead rely on 
perceived pain reports or spinal reflex assessment. 
Although these surrogate measures result in the same 
phenomenon of frequency-dependent increases in pain 
and reflex activity following repeated noxious stimulation, 
further validation and confirmation of precise mechanisms 
underlying TSP in humans is needed.  
 
5.1.2. METHODOLOGICAL CONSIDERATIONS 
Methods of assessing TSP vary considerably, with identified studies in LBP populations alone 
(as per the Systematic Review and updated searches) using everything from sural nerve 
stimulation to evoke withdrawal reflexes, von Frey hairs or pin prick devices to evoke 
mechanical pain, automated thermodes to evoke heat pain and handheld or cuff algometry 
systems to evoke deep tissue pain. Stimulation frequency and duration also varies 
considerably, not to mention stimulus intensity and location of testing. An overview of the 
various paradigms used in papers investigating LBP patients can be seen in Figure 5-2.  
Figure 5-1 Diagram of ascending 
nociceptive pathways with illustration 
showing frequency-dependent 
increase in dorsal horn excitability 
and thus enhanced and prolonged 
neuronal firing after repeated C-fibre 
stimulation 
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Figure 5-2 Variation in Temporal Summation of Pain Paradigms applied in studies of LBP 
patients16,28,32-34,53,55,65,71,74,84,88,91,93,100,137,142,148,169-171,190,196,197,203,211,221,222,243,260,263,265,287,295,307,308,319,320,327,328,332,334,344,345 
(Updated from Systematic Review Supplementary Material to include present studies, articles without 
healthy comparators in LBP populations and articles published after meta-analysis searches were 
complete). Note: depictions are based on manuscript descriptions and hence accuracy is dependent on 
reporting quality, *denotes that study contains more than 1 method, bold indicates inclusion in the 
Systematic Review and Meta-analysis. 
 
As yet, it is not entirely clear what relevance the modality has to findings, though mechanical 
stimuli have previously been suggested to be most convincingly affected in LBP243. It is further 
well established that the frequency and duration of stimuli can influence the magnitude of 
facilitation observed223,224,257. Another important consideration is how TSP is quantified, with 
different calculation methods (i.e. ratios, raw changes or normalized values) producing different 
results4,313. Typically, TSP should be reported as a relative measure to remove between-group 
differences in initial thresholds or painfulness of single stimuli, but as there are no consensus 
statements on best-practice of this measure, this is not performed uniformly across studies.  
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Theoretically, the wind-up mechanism TSP intends to assess is a segmental phenomenon, 
meaning the body site tested in relation to the location of pain or injury should also be 
considered highly influential. In the case of some modalities, such as the pin-prick, it is common 
practice to assess both the site of most pain and an unaffected hand or foot281. However, with 
other approaches, including spinal reflexes and cuff algometry, assessment sites are limited by 
practical accessibility. One could argue that testing a non-painful site, innervated by the same 
spinal segments as the painful site (such as the leg in LBP or the arm in neck pain conditions), 
would provide the cleanest measure of TSP by avoiding influences of peripherally sensitized 
tissues; however, this remains purely speculation.  
5.1.3. VALIDITY & RELIABILITY OF TSP 
In terms of validity, early human studies used heat stimuli and showed frequency-dependent 
summation of ‘second pain’ responses, assumed to be from C-fibre activation, consistent with 
animal models of wind-up257. Further, parallel use of simultaneous electrophysiological and 
psychophysical outcomes has shown concurrent summation of pain and reflex withdrawals, 
suggesting perceptual ratings do reflect the spinal component to some extent8. Beyond these 
parallel perceptual and reflex findings, the understanding of precise chemical mechanisms 
underlying wind-up from animal work has allowed for further validation of the perceptual 
correlate in humans. Namely, NMDA-antagonists have been shown to reduce TSP in several 
human trials13,109,158. More recently, studies using fMRI in the cervical spinal cord and brainstem 
have demonstrated increased activity in dorsal horn regions following repeated stimulation36,37, 
consistent with observations of wind-up in animals. However, these studies also naturally 
observed activation in regions involved in descending inhibitory pathways during the TSP 
paradigm. In combination, these findings suggest that TSP paradigms may reflect changes in 
dorsal horn excitability to some extent, though should be interpreted as a net facilitatory 
response in humans due to the inseparable effect of cognitive-evaluative factors and 
descending controls. Further validation of precise mechanisms in humans is needed, especially 
for TSP from deep structures, which may be achieved with more direct comparisons of methods 
and modalities between animal and human models.  
As in Chapter 4, the control participants in Study II allowed for analysis of reliability between-
sessions. For TSP, this gave an ICC3,k of 0.652 [0.268, 0.834], meaning the method was 
moderately reliable over the study timeframe, and of similar reliability to that reported over 
shorter-intervals in the literature105.  
5.2. FINDINGS ON THE RELATIONSHIP BETWEEN LOW BACK 
PAIN & TSP 
5.2.1. PAIN VERSUS PAIN-FREE 
Temporal summation of pain seemed to be impacted by the presence a RLBP episode at the 
time of testing, both compared between-groups to controls and within-group to the pain-free 
session (Study II, Figure 5-3). This parallels findings from two prior small prospective cohort 
studies, showing trends for TSP to increase in LBP patients with ongoing pain at 2-4 months, 
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compared to either those whose pain reduced251 or to pain-free control data190. However, pain-
related fluctuation in TSP was unable to be replicated in the DOMS model (Study I) with no 
significant differences noted between sessions, nor in the CLBP group (Study III) where no 
changes in TSP were observed throughout the entire study period. On statistical comparison 
across all studies (I-III), no significant group differences were observed (Appendix C). This may, 
however, be due to the small magnitude of these differences, higher inter-individual variability 
in outcomes and mild LBP symptomatology; as in the Systematic Review, TSP was significantly 
facilitated in both acute and chronic LBP patients compared to controls (Fig 5-3). In addition, 
differences between the present and previous findings may also be due to the remote 
assessment site used here, as wind-up is considered a segmental phenomenon and thus 
greater alterations may have been seen if TSP was assessed over the lower back. This is, 
however, difficult to perform reliably using a deep-tissue stimulus, and in the Systematic Review 
no differences in effect size were observed dependent on test site using other modalities.  
It was suggested in the Systematic Review and Study II, that facilitation of TSP was likely to be 
the product of ongoing nociception, consistent with the measure’s theoretical underpinnings. 
However, as discussed in Study II, the apparent effect of LBP on TSP may also reflect 
differences in perceptual or evaluative processes when individuals are in pain. Perceptually 
rated TSP has previously been reported to relate to anxiety278, fear-avoidance beliefs89 and 
pain catastrophizing46,90,274, and given both anxiety and PCS scores were higher in RLBP 
patients when pain was present, it is difficult to disentangle which factor is driving these effects.  
 
Figure 5-3 Pain intensity across TSP stimulation series as normalized VAS-epochs (i.e. 
normalized by subtraction to first stimulus rating, then presented as mean (+/-SEM) of stimuli 2-
4, 5-7, and 8-10) for controls (Study II) and from a painful (P) and non-painful (NP, Study I-II) or 
less painful (LP, Study III) session for each LBP group. Standardised mean difference (SMD) and 
confidence intervals (CI) from Systematic Review (SR) presented as expected effect size from 
control groups 3rd VAS-epoch (dotted line). Note: *denotes significant between-sessions difference 
within the RLBP group in Study II; Meta-analysis results from the Systematic Review shown as yellow 
(acute/recurrent; SMD = 0.51 [95% CI: 0.16, 0.85]) and red (chronic; SMD = 0.55 [95%CI: 0.30, 0.81]) 
diamonds; illustration of paradigm in top left corner.  
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5.2.2. EFFECTS OF PAIN SEVERITY ON TSP 
In the Systematic Review, a weak but significant positive correlation was found between pain 
severity and the standardized mean difference in TSP between-groups. Such a relationship 
was also replicated in Study I, whereby participants with increased TSP at baseline developed 
more severe pain following the fatiguing exercise. Further, when TSP data from the most painful 
session of all LBP conditions (Studies I-III) was collated, a weak positive correlation was also 
found between TSP (represented by VAS-epoch III) and maximum pain intensity (R=0.258, 
P<0.05). From a theoretical perspective, this makes sense, as increased excitability of dorsal 
horn neurons and thus enhanced transmission of nociceptive input, would lead to greater pain 
perception. In line with these findings, prior work has identified relationships between TSP and 
both chronic post-operative (e.g. post-arthroplasty141,250 and post-thoracotomy352) pain severity 
and analgesic responses108,253, though relationships among patients with spinal pain have been 
less clear136. There is some evidence from prior studies that TSP may co-vary with LBP 
intensity, both on experimental induction29 and with changes in response to interventions28, 
though these were relatively minor effects observed in small samples. However, it is also 
possible that this relationship between LBP and TSP is present instead due to concomitant 
effects of perceptual features, such as pain-related fear or pain catastrophizing, as these 
factors are not commonly accounted for in analyses. Nevertheless, the present work seems to 
suggest both that facilitated TSP co-occurs with pain and presumed nociception, possibly in a 
severity dependent manner (Study II), but also that variation in TSP among pain-free individuals 
may be predictive of future pain experiences (Study I). These suggestions require further study 
to refine and confirm, especially in idiopathic musculoskeletal pain conditions.  
5.2.3.   INSIGHTS FROM COMPARISON TO ‘THE STANDARD’ 
Considerable variation in methodology was noted in the Systematic Review, however the pin-
prick approach from the German Neuropathic Pain Network’s (DFNS) QST battery was the 
modality reported most frequently. Although not a primary outcome, and thus not reported in 
the main analyses, this outcome was also assessed in Study II of the present work at both the 
spinal level of most LBP and at the ipsilateral hand dorsum. A problem was encountered, 
however, with this approach, as despite performing the assessment in accordance with the 
DFNS protocol281 (i.e. 1 vs 10 stimuli at 1Hz with a 256mN pin-prick stimulator), there were 
106/448 instances where participants reported an NRS of 0 that needed replacement for ratio 
calculations. Further, these ratios then showed no clear relation to cuff TSP, with within-
session, group and site correlations varying from -0.3 to 0.6. This is not unprecedented, as 
DNRF reference papers also report considerable between-subject variability in pin-prick TSP 
making it difficult to demonstrate abnormalities in patients281. However, there is also reason to 
believe that true differences exist in the extent of hyperexcitability elicitable by muscle and 
cutaneous nociceptors; for example, on the basis of seminal animal works showing prolonged 
dorsal horn discharge after muscle versus cutaneous afferent stimulation132,346. These different 
modalities may offer insight into distinct phenomena related to the different tissue-types 
assessed, though this requires further investigation to establish. On this note, the Systematic 
Review highlighted differences between modalities, with reflex withdrawals to electrical stimuli 
showing the largest between-group alterations, consistent with claims that this modality may 
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have discriminative value for chronic LBP221. Different modalities may, therefore, also be best 
suited for differing purposes, for example these electrical approaches may be most useful in 
diagnostics, whereas mechanical modalities including cuff pressure algometry, with their 
increased inter-individual variation, may have more utility in prognostics. 
5.3. SUMMARY 
There is substantial variation in TSP methodology, and as yet, the relevance of different 
paradigms to outcome and condition remains poorly studied. Nevertheless, meta-analysis 
showed differences in TSP between LBP patients and pain-free controls, with greater 
facilitation of TSP being associated with higher pain severity. The effect of LBP on TSP was, 
however, not consistent between the present experimental studies, with facilitation only shown 
in the presence of a RLBP episode and not from experimental nor mild chronic LBP in the small 
sample studied here. It was suggested that TSP may reflect current pain status to some degree, 
but also that variation among pain-free individuals may be of predictive value in determining 
the severity of future pain experiences. 
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CHAPTER 6. ANTI-NOCICEPTIVE 
DESCENDING PATHWAYS 
In this chapter, conceptual development of conditioned pain modulation (CPM) assessment in 
humans, methodological considerations, and findings from the present work on the impact of 
LBP on this measure (Systematic Review and Studies I-III) are presented and discussed.    
6.1. ASSESSING DESCENDING INHIBITORY PATHWAYS 
6.1.1. DIFFUSE NOXIOUS INHIBITORY CONTROL 
‘Diffuse noxious inhibitory control’ (DNIC) was first coined by Le Bars and colleagues165 in 1979 
to describe an inhibitory spino-bulbar-spinal loop. This was originally established in animals as 
a global inhibitory mechanism activated by strong noxious stimulation of an extremity site 
(typically nose or tail), leading to dramatically reduced firing in wide-dynamic range neurons of 
the dorsal horn in response to concurrent stimulation of heterotopic sites165,166. A significant 
amount of work has been done to 
corroborate this DNIC mechanism in 
humans355 and elaborate on the precise 
descending pathways involved38,61,279,338,354. 
At present, it is understood that these 
descending pathways originate in the locus 
coeruleus (inhibitory) and rostral 
ventromedial medulla (inhibitory and 
excitatory) and project downward to the 
dorsal horn, with noradrenaline being the 
primary neurotransmitter involved in 
generating inhibition21-23. The periaqueductal 
gray (PAG) in the midbrain is also considered 
an important origin of descending inhibitory 
pathways, though more so in inhibition due 
to cortical influences (as this region 
integrates input from e.g. hypothalamus, 
amygdala, rostral anterior cingulate cortex) 
rather than specifically due to 
counterirritation22,242,339. 
6.1.2. CPM – THE PERCEPTUAL CORRELATE OF DNIC  
Initial papers in humans used much the same stimulation methodology as in animals; meaning 
a test stimulus (e.g. pain threshold) was applied before and during a painful heterotopic 
conditioning stimulus (e.g. cold water bath or nasal septum clamp)355. Similar to TSP, this had 
to be done sans invasive recordings, which again meant adopting outcomes of nociceptive 
Figure 6-1 Illustration of DNIC/CPM paradigm 
including ascending nociceptive and descending 
inhibitory pathways, along with relevant cortical 
and subcortical regions involved 
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withdrawal reflexes, perceptual ratings, or both. In fact, early studies using both measures 
demonstrated highly consistent results355, and subsequent work has confirmed good 
correlations between reflex and perceptual pain thresholds204; so many human test paradigms 
now rely on perceptual outcomes alone361. In exploratory studies, CPM measurement has 
shown some value in predicting future disability in LBP patients68, and predicting prognostic 
and treatment outcomes in other painful musculoskeletal conditions69,92,234. 
6.1.3. METHODOLOGICAL CONSIDERATIONS 
The use of non-invasive testing methods in a conscious person introduces several 
methodological issues, due to the involvement of pain evaluative cortical processes. This 
means the measure is no longer likely to be a sole reflection of the classic ‘DNIC’ spino-bulbar-
spinal loop. Especially for methods using pain ratings or thresholds, CPM may be more 
representative of perceptual features than spinal nociception176; though even reflex responses 
are not immune to cognitive interference63, and, as mentioned, have previously been shown to 
correlate with perception anyway355. Prior studies have demonstrated expectation82, 
distraction131,207,208, pain catastrophizing52,324,353 and affective state70,213 to impact the 
magnitude of CPM recorded. Mechanistically, these psychological influences are unsurprising 
due to ongoing communication between cortical regions and brainstem origins of descending 
controls181. Other personal factors, such as age112, gender299, menstrual cycles273, sleep303,305, 
alcohol consumption149 and physical activity95,217,293,330 have also been purported to be 
influential121,201; which seems rational mechanistically given the central role of monoamines 
(e.g. dopamine, noradrenaline, serotonin) in these modulatory pathways22. In the present work, 
most of these factors were either recorded and shown to be consistent between sessions 
(Appendix C) or were controlled for with standardised instructions and use of within-participant 
or matched-control designs. Nevertheless, it is important to remember that psychophysical 
CPM assessment reflects a net response of the whole system, not just that of the intended 
descending pathways.    
Beyond these influences, another general issue with CPM testing is that precise test 
methodology varies considerably between research groups and studies75,145. As demonstrated 
in Figure 6-2 below (updated from supplementary material of Systematic Review), in papers 
looking at LBP alone there are at least 23 different test paradigms using combinations of 8 
different test modalities with 6 different conditioning modalities. This is not to mention additional 
variation in test and conditioning stimulus intensities, stimulus timing and application sites 
between studies, which can also influence outcomes. Although consensus papers have 
emerged recommending ways to standardise testing, few articles follow these 
recommendations361, not least because there is ongoing debate on the relevance of stimulus 
combination and temporo-spatial array to outcome139,214. As a result, methodology selection in 
the present work was based on prior studies showing good reliability with cuff 
measures105,140,252, available equipment and theoretical rationales of modality relevance to 
LBP. In addition, the CPM method used here was extended, compared to prior work using cuff 
algometry, to include an extra ramp to assess pain thresholds prior to conditioning, to observe 
habituation to repeated cuff stimuli. As well, ramped assessments both during and following 
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conditioning were collected to look at both parallel and sequential CPM effects, as there is still 
debate around which is most reflective of descending inhibitory function (Fig 6-2).   
 
 
Figure 6-2 Variation in Conditioned Pain Modulation Paradigms applied in studies of LBP 
patients6,54,55,68,71,79,82,94,100,101,149,150,155,157,160,161,169-171,190,193,196,205,206,211,222,237,243,262,263,265,267,287,314,333,334,344,345,349 
(Updated from Systematic Review Supplementary Material to include present studies, articles without 
healthy comparators in LBP populations and articles published after meta-analysis searches were 
complete). Note: depictions are based on manuscript descriptions and hence accuracy is dependent on 
reporting quality, *denotes that study contains more than 1 method, bold indicates inclusion in 
Systematic Review and Meta-analysis, Red rectangle indicates paradigm used in Study I-III. 
 
6.1.4. VALIDITY & RELIABILITY 
In the present work, a computerized cuff algometer was used to assess CPM. This system is 
user-independent and hence allows for standardisation of stimulus application and timing, as 
well as allowing for individualisation of test and conditioning stimulus intensities based on 
participant pain thresholds or ratings103. It was again assumed that this stimulation type is of 
most relevance to musculoskeletal pain, due to the compression of deep tissues, though this 
remains speculative.  
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Recently, this cuff methodology was back-translated and validated as an appropriate stimulus 
type and configuration to activate DNIC, with findings in rodents paralleling psychophysical 
responses in humans58. Prior human studies have also shown this or similar cuff methodology 
to be able to produce consistent CPM responses when repeated in quick succession130, along 
with being highly reliable over short retest intervals (hours)50 and moderately reliable when 
repeated over longer intervals (weeks)103. Although not yet a diagnostic or discriminative tool, 
this method has also demonstrated some relation to clinical features332 including prognosis. It 
can be debated whether applying both the test stimulus and the conditioning stimulus within 
the same spinal segmental innervation is wise, as this may introduce additional intra-spinal 
inhibitory processes. However, such an approach has recently been shown to produce some 
of the most reliable results229 and generally CPM magnitude does not vary significantly 
regardless of test stimulus site, so long as it is not immediately adjacent to conditioning140,151.  
As for all prior measures, CPM reliability across the study timeframe in the present work was 
tested in control participants from Study II. This demonstrated an ICC (3, k) of 0.567 [0.091, 
0.794] for the parallel-CPM measure, and 0.605 [0.170, 0.812] for the sequential-CPM 
measure, which is consistent with prior reports of reliability for this modality103. Among other 
CPM reliability studies, reports have varied dependent on the testing timeframe, CPM paradigm 
and statistical methodology used140,145, with some reporting good to excellent reliability7,31,50,172 
and others poor reliability239,356. As is evident from the literature, presented statistics, and the 
later findings (Figure 6-3), reliability with the present methodology is acceptable, but inter- and 
intra-individual variability in CPM is generally high. This remains a critical issue for researchers 
and clinicians looking to use CPM for diagnostic and/or prognostic purposes.    
6.2. FINDINGS ON THE RELATIONSHIP BETWEEN LOW BACK 
PAIN & CPM 
6.2.1. EFFECTS OF PAIN PRESENCE & SEVERITY 
The Systematic Review identified impaired CPM in patients with LBP compared to control 
participants overall. Similarly, an overall group difference in CPM between RLBP patients and 
controls was demonstrated in Study II. However, no statistically significant alterations in CPM 
were identified between-sessions within experimental (Study I) or clinical (Study II & III) LBP 
groups, suggesting pain presence on the day of testing did not have a clear impact on CPM 
magnitude. To some extent, this would support the concept of CPM efficacy as a trait measure, 
potentially reflecting a mechanism that contributes to, or enhances susceptibility to pain 
maintenance and thus allowing for predictive value in prognostics. In line, CPM has been 
reported as a predictor of prognosis and treatment response in numerous studies69,92,108,133,284, 
though the degree of relation between CPM and outcome is variable. As well, prognostic 
capacity in spinal pain conditions specifically has so far been lacking, with most large-scale 
prospective cohort studies showing limited to no utility in predicting treatment response or long-
term changes in pain68,79,161,171,206,211,287, though a possible relation to disability68. Difficulties in 
demonstrating prognostic utility could, however, be a result of methodological issues like high 
variability and the confounding influences of various individual and contextual characteristics.
CHAPTER 6. ANTI-NOCICEPTIVE DESCENDING PATHWAYS 
35 
A relationship between pain severity and CPM impairment was also observed in the Systematic 
Review. As there was a lack of effect of pain presence in the present experimental studies 
(Study I-II), this may instead suggest that the intensity of LBP was simply not sufficient here to 
acutely impair CPM, but that more severe LBP could have. In line, prior experimental work 
using more painful provocations, such as hypertonic saline14 and capsaicin129, have been able 
to demonstrate acute impairment of CPM, and clinical studies in populations with more severe 
pain have also shown normalization of CPM following pain-relieving procedures106,154. 
Interestingly, a relationship between LBP severity and impaired CPM has also been evident 
within some individual studies100,332, though more commonly reported is a relationship between 
CPM impairment and the spatial extent of pain6,94,101,334. The present work did not investigate 
this question, as included patients primarily reported localized LBP. However, as widespread 
pain is often associated with greater disability, this warrants further study to determine whether 
impaired CPM prior to or soon after pain-onset can predict spread of LBP, or alternatively if the 
mechanism becomes more impaired with expanding pain areas. 
 
 
Figure 6-3 Mean (+SEM) CPM effect, as increase in cuff pain detection (cPDT) and tolerance 
(cPTT) thresholds from the first ramp to the 2nd (faded, prior to conditioning), 3rd (during 
conditioning) and 4th (immediately following conditioning) ramps, for controls (Study II) and from 
a painful (P) and non-painful (NP, Study I-II) or less painful (LP, Study III) session for each LBP 
group. Standardised mean difference (SMD) and confidence intervals (CI) from Systematic 
Review (SR) are presented as expected effect size from control group mean of ramps 3-4 (dotted 
line). Note: *denotes significant main effect of Group within Study II where RLBP patients showed 
reduced CPM compared to controls. Meta-analysis results from the Systematic Review shown as yellow 
(acute or recurrent; SMD = -0.11 [95%CI: -0.30, 0.08]) and red (chronic; SMD = -0.57 [95%CI: -0.82, -
0.33]) diamonds; illustration of paradigm provided in top left corner. 
 
6.2.2. RELATIONSHIPS BETWEEN PAIN DURATION & CPM 
When data in the Systematic Review was sub-grouped into acute and chronic, only chronic 
LBP patients showed significantly lower CPM compared to controls (Figure 6-3). On a group 
level, mean pain duration also significantly correlated with CPM. Such a relationship was not 
clearly demonstrable in the experimental studies of this thesis, though this may have been due 
to the small samples of comparatively mild recurrent and chronic LBP patients included. Some 
prior studies have shown a relationship between pain duration and CPM impairment in patients 
with knee osteoarthritis10,81, though not consistently12,298, and this relationship has not been 
replicable in various other painful musculoskeletal conditions107,120,240,323. Nevertheless, if this 
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relationship truly exists in LBP, it suggests either that there is a temporal degradation in pain 
inhibitory mechanisms due to ongoing nociception and pain, or that inefficient CPM prior to or 
in the acute phase of pain contributes to pain recurrence and/or persistence. Consistent with 
the former, a recent small longitudinal study following patients after spinal cord injury showed 
reductions in CPM over time as neuropathic pain was maintained85. However, this was not the 
case for musculoskeletal pain in this patient group, suggesting interactions between CPM 
efficacy and pain persistence may depend on underlying mechanisms. When instead looking 
at musculoskeletal pain populations, there is some preliminary evidence to suggest impaired 
CPM may precede development of chronic neck pain290, but this requires replication in larger 
samples and other painful musculoskeletal conditions.   
6.2.3. INSIGHTS FROM CPM TESTING  
The reason for the lack of differences observed between painful and pain-free sessions in the 
present work could very well be primarily due to variability. As well, based on the present 
studies, pain detection thresholds do not appear to be an ideal test stimulus, despite their 
frequent use (Figure 6-2). This is because some degree of habituation occurs on repetition of 
the stimulus alone (i.e. Ramp 2 in Figure 6-3) especially in control participants, followed by 
highly variable findings for the two subsequent ramps (i.e. ramps during and following 
conditioning, though these do correlate significantly). On the contrary, pain tolerance thresholds 
appear to be more stable, showing less habituation on reapplication and more consistent 
inhibition during and following conditioning. This is in line with the initial papers on CPM in 
humans, where intolerable pain was demonstrated to be more sensitive to the conditioning 
stimuli tested than threshold pain355. It also parallels recent animal findings showing the 
direction of modulation to be dependent on test stimulus intensity, with only the more noxious 
test stimuli demonstrating inhibition316. 
On the matter of habituation to repeated threshold testing, it is noteworthy that this was most 
problematic in controls and less evident in LBP populations (Studies I-III). It was also the case 
that experimental LBP appeared to reduce habituation in controls, albeit non-significantly on 
post-hoc testing (Study I). Early QST studies in LBP patients highlighted this phenomenon of 
lacking habituation to repeated stimuli as a discriminative feature of chronic LBP248,249, and 
posited that it may be mechanistically linked to chronic LBP development and/or LBP 
persistence39. Recent work has further shown lacking habituation in cortical responses to 
painful stimuli among CLBP patients compared to controls, again suggesting this to underlie 
pain persistence343. The present work would instead tend to support this being a consequence 
of LBP presence (Study I), but it is still open for further investigation. In reality, the results seen 
here are probably explained by a combination of: lacking capacity to habituate due to 
hyperexcitability e.g. in ascending nociceptive pathways, reduced descending inhibitory 
function, hyperawareness of sensory stimuli producing more accurate and thus consistent 
ratings, and persistent anxious or catastrophic thoughts despite lack of stimulus novelty; though 
this is merely speculation.  
Although this was not the focus of the present work, two alternative CPM paradigms were tested 
in some of the study populations (Study I-II). This was primarily to develop test methodology 
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that was able to be used concurrently with affective and attentional manipulations (unpublished 
supplementary work), but also to develop a cuff pressure-based approach that was more 
consistent in timing and outcome with typical thermal paradigms (i.e. where a brief noxious test 
stimulus is applied and evaluated with pain ratings before and following a period of 
conditioning259). Unfortunately, the first of these approaches using two 5-second test stimuli 
prior to and following conditioning was ineffective (Study I), producing no measurable inhibition 
in healthy controls. However, the second approach using three 1-second test stimuli prior to 
and after 75-seconds with ongoing conditioning seemed to produce inhibition and demonstrate 
results consistent with the ramped approach for RLBP patients and controls (Study II). Further 
work is needed to elaborate on these findings and determine the relevance of different stimulus 
arrangements; but, perhaps with significant methodological refinement, and open publication 
of large normative datasets for reference, CPM may eventually be of clinical use. 
6.3. SUMMARY  
In papers on LBP alone, there is considerable variation in stimulus parameters used to assess 
CPM. Even when using the same paradigm, there is high inter- and intra-individual variability, 
which greatly hinders the comparability and interpretation of results. Nevertheless, impaired 
CPM was shown on meta-analysis, driven by changes observed in CLBP patients. In the 
present experimental studies, a recently back translated and validated method was used. This 
method identified impaired CPM among RLBP patients compared to controls within Study II but 
could not elucidate other differences between groups or sessions. Additional relationships 
between CPM degradation and both pain duration and severity were observed in the meta-
analysis but could not directly be replicated in the present experimental work. It remains unclear 
as to whether impairments in CPM are consequential or contributory to pain persistence, as 
there is evidence consistent with both possibilities. 
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CHAPTER 7. ATTEMPTS TO MODULATE 
PAIN SENSITIVITY 
From the present work, there appeared to be a relationship between LBP and impaired CPM 
(Systematic Review & Study II). In the Systematic Review, this manifested as an overall group 
impairment in especially chronic LBP patients compared to controls, the magnitude of which 
was moderately correlated to pain duration. Then in Study II, a similar group level impairment 
was observed without normalisation in the pain-free period, unlike the other measures. If CPM 
impairment were to represent a relevant pathophysiological feature of LBP, it would seem 
pertinent to attempt to modulate this mechanism and examine the resultant impact on the pain 
experience. In clinical populations showing impaired CPM, such as patients with painful diabetic 
neuropathy, duloxetine (a serotonin and noradrenaline reuptake inhibitor) and Tapentadol (a 
combined opioid and noradrenaline reuptake inhibitor) have shown some efficacy in restoring 
inhibitory function225,362. This has been mechanistically corroborated in animals25,363 though has 
proven difficult to reliably replicate in other patient groups147. Other strategies addressing 
known influential factors (such as attempting to increase physical activity, improve sleep or 
enhance mood), could also improve CPM in patients with those specific factor-related 
problems. However, this introduces difficulties in disentangling effects, as these factors also 
interplay heavily with both one another and the clinical pain experience. An arguably cleaner 
and/or simpler approach would be to intervene by stimulating cortical or sub-cortical regions 
involved in controlling descending noxious inhibitory pathways, which also allows for a sham 
comparison to check efficacy. This approach was used in Study III and is also currently being 
trialled in larger scale work elsewhere49,317.  
7.1. NON-INVASIVE BRAIN STIMULATION  
7.1.1. TRANSCRANIAL DIRECT CURRENT STIMULATION 
Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation, where 
weak electrical direct currents are applied to the scalp through specifically placed electrodes in 
order to alter cortical excitability in particular brain regions. Over the years, tDCS has been 
studied as a way to cure numerous ailments5,366, including pain. In contrast to other forms of 
stimulation and pharmacological management, the technique offers the advantages of being 
non-invasive, more tolerable, accessible, relatively low cost and easy to apply. Thus far, 
efficacy has been shown among patients with post-surgical and chronic neuropathic pain 
conditions59,152,232,254, though effects on experimental pain sensitivity are inconsistent97,212.  
7.1.2. TARGETING STIMULATION  
Various stimulation targets have been trialled with tDCS to address pain and related symptoms 
in patients152,254. The motor cortex is most commonly used184, perhaps foremost because of its 
definitive localisation, along with the promise shown in studies of repetitive transcranial 
magnetic stimulation applied to this region. Motor cortex tDCS has also been used to acutely 
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improve descending inhibitory processes in healthy individuals80; however, no acute changes 
in QST parameters were provoked after a single session in CLBP patients183.   
Regarding descending inhibitory processes, various cortical regions are thought to have 
influential connections with descending inhibitory pathways, allowing for the pain-modulating 
effects of cognitive engagement and affective manipulation339. As the main source of cortical 
projections to the periaqueductal gray (PAG) are from the medial prefrontal cortex (mPFC)24,364, 
and as this region is also heavily involved in affective processing266, this was considered an 
ideal location to target159. This region was additionally of interest since both impaired CPM and 
affective symptoms are commonly present in LBP patients and are suggested to influence pain 
progression. As well, fMRI and electrophysiological investigations in LBP patients have shown: 
altered functional connectivity within and between the mPFC and PAG during LBP 
exacerbation195,329,365, altered activity in these same regions in response to noxious 
experimental stimuli65,99,175,195 and morphological alterations generally in prefrontal areas156.  
Stimulation targeting was based on a previous HD-tDCS study, which had used a high-
definition array to target an mPFC subregion, namely the anterior cingulate cortex (ACC)322. 
Based on the computer modelling in this study, the HD-tDCS array appeared to generally target 
the medial prefrontal region, so was deemed appropriate for use here. The electrode 
arrangement (see Figure 7-1 below) includes with one central anode over the frontal vertex 
(Fz) and four surrounding cathodes at FP1, FP2, F7 and F8. Modelling was independently 
repeated in MatLab using SimNIBS software321 (Figure 7-1) with appropriate tissue 
impedances, electrode properties (i.e. as specified by Neuroelectrics®) and stimulation 
parameters (2mA anodal direct current) for the present work, again showing current flow 










‘Ernie’ dataset and 
Study III electrode 
parameters).   
 
7.1.3. CONTROLLING FOR CONTEXT VIA SHAM TDCS 
To attribute changes in symptomatology and pain sensitivity measures to active tDCS, a sham-
comparator was essential. Much debate has arisen regarding sham paradigms, especially 
regarding their efficacy in crossover trials, as there are perceptible differences in the sensations 
produced146,231,283. In the present work, a long (60s) ramp on and off was used in both conditions 
to better mimic the duration of sensations at the beginning of the active paradigm. Participants 
were also given no specific details regarding differences in timing or intensity between 
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paradigms. Instead, they were informed of the expected sensations from stimulation, such as 
that they may feel itching, tingling and warmth, and were told that these sensations would be 
strongest in the first few minutes, then slowly fade away irrespective of the paradigm. These 
decisions were based on recommendations from prior literature suggesting that longer sham 
stimulation duration and managing expectations could improve blinding success41,245,271.  
Despite the fact this was a crossover trial, with participants acting as their own controls, blinding 
failure did not appear to be a major issue in the present work. Only 58.3% of participants 
correctly guessed which protocol they received, which was not statistically different from 
chance, and only reported a median certainty of 2-3 (on a 5 point-Likert scale from not at all to 
completely certain, Study III). Participants typically reported guessing the active protocol based 
on either more intense sensation during stimulation or reduced back pain, but these guesses 
were frequently wrong. Side effects were also commonly reported in both conditions further 
aiding blinding maintenance for both participants and experimenter. This strengthens study 
conclusions, and suggests that cross-over designs are appropriate, at least for pilot testing. In 
future studies with larger samples, it would be interesting to look at differential effects based 
on believed treatment, but this was not possible in the present work.  
7.2. FINDINGS ON THE EFFECTS OF TDCS 
An overview of the design of Study III can be seen in Figure 2-3 and a summary in Appendix 
A. In short, Active and Sham tDCS were applied to the mPFC of CLBP patients each on three 
consecutive days, separated by at least two weeks. Self-report data was collected at the start 
of each session and pre- and post-stimulation, while pain sensitivity measures were assessed 
pre- and post the first day of stimulation, immediately and 24-hours following the third day of 
stimulation, and on Day 21 in each phase. Overall, the active and sham tDCS both reduced 
current pain intensity in the immediate post-stimulation period of the first session, but no long-
term changes (on Day 4 or 21) in pain ratings were noted (Figure 7-2).  
Figure 7-2 Intensity (left) and unpleasantness (right) of pain both on average over the preceding 
24 hours (Day 1, 4, 21) and immediately prior to and following tDCS (Day 1-3) for the active 
(yellow) and sham (blue) HD-tDCS paradigms. Note: *denotes a significantly larger reduction in pain 
ratings on Day 1 than Day 2-3 as demonstrated on normalised data in Study III Supplementary Material. 
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In terms of pain sensitivity measures, cuff pain tolerance thresholds were increased over time 
in both paradigms (Fig 7-3), suggesting general temporal habituation rather than a tDCS-
related effect. Normal TSP and CPM responses were present (Fig 7-3) and of similar magnitude 
to healthy controls in Study I-II (Fig 5-3, 6-3, Appendix C), and these were unchanged by either 
tDCS paradigm. In the supplementary material of Study III, immediate effects of tDCS were 
also explored (greyed bars in Fig 7-3), in which there was a reduction in ECR PPTs following 
active compared to sham tDCS, likely related to generally higher PPTs on Day 1 in the active 
phase, but otherwise no differential effects were observed between tDCS paradigms.  
 
Figure 7-3 Overview of results for main psychophysical outcomes across testing sessions on 
Day 1 pre and post stimulation, Day 3 post stimulation, Day 4 and Day 21, for Active (yellow) and 
Sham (blue) HD-tDCS conditions. Note: §denotes overall higher cuff thresholds at Day 21 than Day 1 
Pre (pain tolerance), *denotes significant main effect of Epoch / Ramp showing TSP and CPM (on cPTT 
only) effects to be present overall. 
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7.3. COMPLEXITIES OF MODULATING ANTI-NOCICEPTION 
Although this HD-tDCS paradigm intended to target cortical projections to descending inhibitory 
pathways, and thus alter pain modulatory efficacy, it is safe to say that it did not produce major 
effects. There are many features of the present work that could explain this lack of efficacy, for 
example: (1) CLBP patients already demonstrated efficient CPM at baseline; (2) the modelling 
of penetration depth is based on an ideal situation with little electrode to scalp impedance, 
whereas in reality, some participants in the present study had long and/or thick hair making it 
difficult to achieve a low impedance; (3) A-priori sample size calculations were conducted but 
the sample remains small and heterogeneous; (4) included patients generally demonstrated 
mild LBP features at the time of testing and no clear affective disturbances; and (5) stimulation 
targets were based on functional connectivity findings, which may be problematic if these 
regions are not actually involved in the functions posited, or if their involvement is in processing 
present pain state rather than representing a feature relevant to the LBP condition51,60. In 
addition, a prior study aiming to intervene with affective features of CLBP by targeting the ACC 
(albeit with a different electrode type and array) showed greater promise in improving pain and 
disability191, but also used many more sessions (10 versus 3 here) and did not assess CPM.    
Generally, there has been ongoing debate about the efficacy of tDCS, with a recent review 
questioning whether it can produce any neurophysiological effects at all134. This large-scale 
meta-analysis showed significant effects on only 1/30 neurophysiological outcomes (motor-
evoked potentials) and even that effect had been declining over the preceding decade134. In 
clinical trials, systematic review conclusions also vary widely with some suggesting great 
potential in pain management97,179,254, and others suggesting limited to no efficacy184,232, 
including for CLBP3. For QST measures, a recent review97 was positive, showing ‘homogenous’ 
improvements in CPM across studies (following motor cortex stimulation), but effect sizes were 
still small. It may be the case that combined strategies (i.e. tDCS with concurrent exercise, 
psychological or pharmacological intervention) produce greater effects44, by capitalizing on the 
post-tDCS window of enhanced excitability254, but this requires further investigation in large-
scale, well-controlled clinical trials.  
Based on findings from the Systematic Review and Study II, the hope was that taking a group 
of CLBP patients would mean having a population with deficient CPM, which tDCS could then 
help to restore. It was thus problematic that the small sample of CLBP patients recruited here 
did not demonstrate deficiencies in CPM at baseline, as exploratory correlations within the 
study did actually support an improved effect of tDCS in those with most impaired CPM at 
baseline. The normal CPM responses observed in this sample may result from their relatively 
mild LBP symptoms, low disability, young age and high physical activity levels; suggesting that 
recruiting an older and more severely impacted CLBP population, or screening participants 
prior to inclusion, may have resulted in a different outcome. As also highlighted in a recent 
review254, strict screening should be considered in future work. Beyond variation in CPM, it is 
important to consider that individual differences in brain state prior to stimulation226, anatomical 
variation in brain architecture174, and differences in pathophysiological mechanisms underlying 
an individuals’ pain condition may all also contribute to differences in stimulation efficacy. 
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CHAPTER 8. CONCLUSIONS, 
IMPLICATIONS & FUTURE DIRECTIONS 
8.1. SUMMARY OF MAIN FINDINGS 
The present work has suggested that alterations in pressure pain sensitivity and TSP may be 
primarily reflective of present LBP state (Systematic Review, Studies I-III), while CPM may be 
prone to progressive impairment over time as pain transitions from acute to chronic (Systematic 
Review, Study II) and/or mild to severe. A summary of these findings is provided in Figure 8-1. 
 
Figure 8-1 Brief summary of individual study conclusions, as well as summary of findings across studies 
for primary outcome measures overlayed onto conceptual schematic of thesis. 
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In response to the objectives described in Chapter 1, the present work has (I) clarified that 
alterations in both TSP and CPM do indeed exist among patients with LBP, at least on group 
level comparison with pain-free populations. The magnitude of these alterations was small, but 
showed some relation to pain severity and, in the case of CPM, to pain duration. (II) The effect 
of experimental LBP on pain sensitivity measures within-individuals (Study I) was examined; 
demonstrating that the DOMS model reduced PPTs over both local lower back and some 
remote sites, though was unable to alter TSP nor CPM. (III) The impact of clinical LBP 
resolution (Study II) or reduction (Study III) on pain sensitivity measures within-individuals was 
investigated; demonstrating that the presence of pain was associated with hypersensitivity to 
pressure and facilitated TSP at least for RLBP patients (Study II), though CPM remained 
unchanged between sessions (Study II & III). (IV) Pain sensitivity was compared between LBP 
patients and control participants when clinical pain was absent (Study II); showing that RLBP 
patients in remission do not appear different from controls in terms of pressure pain sensitivity 
nor TSP, though do continue to show impaired CPM. 
8.2. CONCEPTUAL CONSIDERATIONS 
Disentangling the effects of present LBP (state), versus having a LBP condition (trait), on pain 
sensitivity measures, and inevitably on other outcomes, is clearly a challenging endeavour. In 
Figure 8-2, a conceptual illustration of the overarching thesis design is shown, indicating the 
comparison possibilities that such an approach gives. This includes: Cross-sectional 
differences between participants with experimental or clinical pain and control participants, as 
performed in much of the existing literature (Fig 8-2, C); Reliability of measures in control 
participants, as is essential to understand if measures are to be of individual predictive utility 
(Fig 8-2, E); Stability of measures in populations with clinical pain to understand the influence 
of present pain state (Fig 8-2, G); And, the effect of having a clinical LBP diagnosis without 
present pain, potentially allowing for elucidation of pathophysiological mechanisms underlying 
the development or maintenance of the condition that could be highly relevant interventional or 
preventative targets (Fig 8-2, F). Each comparison is integral to the understanding of the 
relationship between LBP experience and pain sensitivity measures, and hence the potential 
utility of these measures. However, it is also important to note that attempts to disentangle state 
and trait effects of pain are limited by the variability of both the measures used and the LBP 
experience. It is clear from the present and prior work that significant variation exists between 
pain-free individuals alone, and it is possible that this variation could be useful in predicting 
future pain development, maintenance, or severity, but only if the measures used are valid and 
reliable (Fig 8-2, A). There is also significant variation in the experience of LBP both within- and 
between-individuals, and assessment sessions capture only a snapshot of this experience 
which may or may not accurately reflect the individual or their LBP more generally (Fig 8-2, B). 
As well, if pain presence and/or severity has a major confounding impact on outcome 
measures, then this variation in present pain experience will have ramifications for the 
measures’ prognostic and diagnostic utility, as they may just become a reflection of pain state. 
In addition, various psychosocial and contextual factors can influence both pain perception and 
pain sensitivity, and while these can be assessed through questionnaires or activity trackers, it 
remains challenging to properly separate and control for their effects (Fig 8-2, D). 
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8.3. IMPLICATIONS OF FINDINGS 
Conceptual difficulties aside, the present work has made several observations that could have 
implications both for clinicians treating LBP patients and for future research. Firstly, pressure 
hypersensitivity was heavily impacted by fluctuations in present pain state. Hence pressure 
pain sensitivity measures may be useful to track changes in LBP condition over time and in 
response to treatment, as a supplement to self-reported and other clinical outcome measures. 
Thus far, the prognostic value of pressure pain thresholds has been limited92,234, but it remains 
possible that they may be useful in informing treatment selection and/or understanding variation 
in treatment response. It may also be useful for clinicians to consider that enhanced sensitivity 
to pressure, observed in patients as diffuse tenderness on palpation or general soreness, may 
be more reflective of the present state of the patient (i.e. that they currently have acute pain 
from the presenting condition or other injuries, or maybe even simply because they are currently 
stressed, anxious or sleep deprived, etc.) rather than being indicative of either the severity of 
their pain condition or that there is tissue damage.  
Figure 8-2 Illustration of comparison possibilities and interpretations from the present 
combination of study designs, and sources of variation within pain and pain sensitivity 
measures, demonstrated using excerpts of data from the present experimental works, that 
require elaboration in future work. Note: A. Represents considerable inter-individual variation in 
TSP and CPM when pain-free, B. Shows high variability in pain perception across LBP conditions, C. 
Indicates cross-sectional comparison of pain-free population to patients with present LBP, D. Indicates 
potential influential individual and contextual factors which could be sources of additional variation, E. 
Indicates control comparisons over time provide valuable insight into reliability of outcome measures, 
F. Indicates comparison in which trait features of the LBP condition can be seen without confounding 
effects of present pain, and G. Indicates comparisons within LBP conditions over time provide 
valuable insight into the stability of outcome measures. 
TEMPORAL CHANGES IN PRO-NOCICEPTIVE AND ANTI-NOCICEPTIVE MECHANISMS IN RELATION TO THE 
EXPERIENCE OF LOW BACK PAIN 
48
 
As with pressure pain sensitivity, it may be the case that TSP proves useful in tracking changes 
in pain state over time, as well as having potential for predicting prognosis or aiding treatment 
selection. On this note, this thesis brings an interesting conundrum to light, namely that TSP in 
a pain-free state predicted future pain severity but TSP itself was also altered in the presence 
of clinical pain, suggesting both trait and state properties. It therefore seems imperative to 
consider present pain state during TSP assessment in future work, as the variation observed 
in single homogeneous populations (i.e. patients with the same pain severity, or healthy 
individuals with no pain) may be highly informative of prognostic features, but this natural or 
inherent variance in TSP could be masked by the presence of pain. This is seemingly important 
to consider regardless of whether present pain is related to the condition being studied or not, 
as TSP over an unaffected site (the lower leg) was altered by LBP presence here (albeit within 
similar segmental innervation). As such, ongoing trials are investigating the utility of these 
measures in patient selection for more mechanism-based intervention, which, if successful, 
could improve treatment efficacy in clinical practice. From the present work, however, perhaps 
the key positive takeaway is that these features, especially pressure hypersensitivity and TSP, 
are not ‘fixed’ and should resolve with pain.  
CPM showed some level of impairment generally among LBP patients that increased with pain 
duration. The present thesis could not disentangle whether this was a time-related reduction in 
descending inhibitory capacity, or a change in the proportion of people with dysfunctional CPM 
represented in more chronic populations. Nevertheless, it would seem that CPM impairments 
may reflect a trait feature of LBP conditions, becoming increasingly pronounced with greater 
chronicity. If this is the case, and CPM is actually a relevant feature with a role in LBP 
maintenance, then developing and refining methods to improve or restore CPM could be of 
great benefit in treating LBP conditions or even preventing the recurrence and/or persistence 
of LBP in the first place. This remains to be further explored. However, it is also important to 
remember that, although not significantly affected by pain presence in these studies, CPM is 
often greatly influenced by a range of other state and contextual factors, and has previously 
been acutely altered by more severe pain states, meaning on an individual level it still may not 
be an ideal trait-measure unless suitable control procedures are developed and implemented.  
8.4. FUTURE DIRECTIONS 
This thesis has highlighted methodological inconsistencies in TSP and CPM assessment that 
need to be addressed before significant progress can be made. In particular, understanding 
the relevance of stimulus modality and arrangement in TSP and CPM assessments to specific 
pain conditions, and how these factors affect the test outcome, is essential, both in obtaining a 
valid and useful measure and in allowing for meaningful comparison between trials. 
Fortunately, there are now ongoing global efforts to: compare methodologies from different 
research groups, create standardised testing batteries and generate large normative datasets, 
at least for CPM; which will no-doubt aid our understanding of this measure and its utility. 
Similar global efforts on TSP would also be highly valuable in refining and validating this 
measure and furthering the understanding of its potential predictive capabilities. Once better 
refined, standardised, and understood, if these measures continue to show predictive capacity, 
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future studies should attempt to define cut-off values and develop clinical prediction rules in the 
progression toward truly personalised mechanism-based treatment. 
From a conceptual standpoint, it seems necessary to highlight that the measures of pain 
sensitivity investigated in the present thesis are all ultimately reflective of a net response from 
the individual participant. Although not explored in the present thesis, and while theoretically 
the different pain sensitivity measures intend to assess distinct mechanisms, there are also 
undeniably interactions and relationships between these measures. Prior literature has 
attempted to use this advantageously, by creating indices or phenotypic groups based on 
specific combinations of pain sensitivity measures, which may increase their diagnostic or 
prognostic value. However, much work remains to understand, refine, and forward validate 
these combined approaches.  
The present work has provided a comprehensive approach to understanding the impact of LBP 
presence on pressure pain detection and tolerance thresholds, TSP and CPM. This strategy of 
using cross-sectional (Systematic Review), observational (Study II), forward (Study I) and 
backward (Study III) manipulations could be equally useful in assessing the impact of pain 
presence on other measures and in other disorders, both painful and otherwise, to help 
disentangle state and trait features of pain conditions as highlighted in recent work60. As only 
mild variants of LBP were investigated in this thesis, it is unclear if findings are replicable in 
other subgroups, for example, with greater severity of pain and disability, widespread pain 
features, comorbid conditions, or with neuropathic or radicular symptomatology. It is further 
unclear if the present findings are specific to LBP or musculoskeletal pain alone, or if pain in 
any location from any source could produce some of the same results. Future work is needed 
to expand upon the present studies, both specifically in LBP conditions and otherwise, by 
tracking patients over longer time spans, using more homogenous patient groups (e.g. with 
regard to pain onset and history, temporal profile of pain, disability level, and/or mechanistic 
classifications), and using different experimental pain provocations and clinical interventions 
with stronger effects. It is hoped that with continued work in this direction, a better 
understanding of both the effects of present pain state on measures of pain sensitivity and trait 
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Appendix A. Article Overview 
Overview of the three primary articles included in this thesis 
 STUDY I STUDY II STUDY III 
Title 
Alterations in Temporal 
Summation of Pain and 
Conditioned Pain Modulation 
Across an Episode of 
Experimental Exercise-
Induced Low Back Pain 
Recurrent Low Back Pain 
Patients demonstrate 
Facilitated Pro-nociceptive 
Mechanisms when in Pain, 
and Impaired Anti-nociceptive 
Mechanisms with and without 
Pain 
Medial Prefrontal High-
Definition Transcranial Direct 
Current Stimulation to 
Improve Pain Modulation in 
Chronic Low Back Pain: A 
Pilot Randomized Double-
blind Crossover Trial 
Objective 
To investigate predictive 
value of pain sensitivity for 
LBP development and 
changes in pain sensitivity 
consequential to LBP 
To investigate whether pain 
sensitivity alterations are a 
consequence of LBP presence 
To investigate changes in 
clinical pain and pain 
sensitivity induced by mPFC 
tDCS 
Sample 
30 Pain-free participants 
(6 excluded, no DOMS at 
Day-2) 
30 Recurrent LBP patients 
(4 excluded, 1 withdrew and 3 
with ongoing pain at Day-28) 
30 Pain-free controls 
12 Chronic LBP patients 
(1 missing final follow-up 
session) 
Design 
Data collected at baseline 
(Day-0), post-exercise (Day-
0), with LBP (Day-2) and 
post-resolution (Day-7) 
Data collected with RLBP 
present (Day-0) and resolved 
(Day-28), and over same 
timeframe in controls 
Active/sham tDCS for 3 days 
separated by >2 weeks. Data 
collected pre/post 1st (Day-1) 
and post 3rd session (Day-3), 
at Day-4 and Day-21 
Model 
Delayed onset muscle 
soreness in lumbar erector 
spinae/gluteal muscles, 
induced by repeated prone 
trunk extensions to fatigue 
Subclinical recurrent LBP 
present for >24 hours at time 
of recruitment and testing, that 
is expected to resolve 
completely in less than 4 
weeks 
Chronic LBP with average 
pain score ≥3/10. Stimulation 
applied using HD-tDCS with 
anode at Fz and cathodes at 
F7, F8, FP1 and FP2. 
Materials 
History, physical exam, sleep, menstruation, mood, IPAQ, PCS, Pain VAS intensity and 
unpleasantness, RMDQ, STarT-Back Screening Tool, (Pain-DETECT, BDI) 
Measures 
Handheld pressure pain thresholds (PPTs), cuff pain detection (cPDT) and tolerance (cPTT) 
thresholds, supra-threshold ratings (STR), temporal summation of pain (TSP) and conditioned 
pain modulation (CPM) 
Results 
Mild pain and disability 
provoked. PPTs reduced at 
L1, L5 and ECR compared to 
pain-free, UT and GAS 
reduced to Day-7. Cuff 
thresholds increased at Day-
7. No significant changes 
over time in TSP or CPM. 
Baseline TSP (along with 
lumbar PPTs, number of 
exercise repetitions, mood, 
and gender) associated with 
peak LBP severity 
Mild LBP and disability 
reported. PCS scores higher 
on Day-0 than Day-28 for 
RLBP patients. PPTs reduced 
at L1, L5, ECR and UT on 
Day-0 compared to Day-28 
and controls. cPDT increased 
on Day-28 compared to Day-0 
in RLBP. TSP increased on 
Day-0 compared to Day-28 
and to controls. CPM reduced 
in RLBP patients compared to 
controls overall. 
Mild LBP and disability 
reported. Immediate 
reduction in pain intensity 
observed after first tDCS 
session. No differences 
between Active and Sham for 
pain or questionnaire 
outcomes. No differences in 
pain sensitivity between 
Active and Sham protocols at 
Day-4 or Day-21. Negative 
correlation between baseline 
CPM and response to Active 
tDCS. 
Conclusion 
TSP assessed in a pain-free 
state may help explain 
variation in future pain 
severity. The DOMS LBP 
model produced local and 
widespread pressure 
hypersensitivity but was not 
sufficient to alter central pain 
processing mechanisms. 
A RLBP episode was 
associated with increased pain 
catastrophizing, local and 
widespread pressure 
hypersensitivity and facilitated 
TSP, compared to when pain 
resolved and to controls. CPM 
was reduced overall and may 
represent a relevant feature 
contributing to RLBP 
development or maintenance. 
This mPFC tDCS paradigm 
was unable to produce 
specific changes in pain, 
disability, PPTs, cuff 
thresholds, TSP or CPM, 
possibly due to issues with 
sample characteristics. 
Exploratory correlations may 
indicate potentially better 
effects in a selected sample 
with very inefficient CPM. 
APPENDICES 
APP 3 
Appendix B. Confounding Factors 
Additional details on material used to capture potential confounders 
 
Factor: Rationale: Measures used: Description and validity: 
Sleep Sleep is increasingly 
acknowledged to play a key role 
in painful disorders, with many 
studies implying close links 
between poor sleep and pain 
exacerbation77,116,143,269,296. In LBP 
patients specifically, sleep 
disturbance is 
common17,116,143,192,233,335, with 
more than half of chronic patients 
in recent studies reporting 
insomnia symptoms233,335. 
Further, it has been shown 
previously that both reduced total 
sleep time and interruptions to 
sleep have a detrimental effect 
on pain thresholds282,288,296, TSP 
and CPM73,305.  
- Number of hours 
slept night prior to 
testing session 
(Study I-III) 
- Number of 
awakenings in 
night prior to 
testing session 
(Study I-III) 
These questions are asked in 
validated sleep quality 
questionnaires43 and have adequate 
face validity. Participants tend to 
overestimate sleep duration, but this 
is done so systematically and reports 
still show moderate correlation to 
objective measures164.  
Menstruation There is debate as to the 
influence of female hormonal 
cycles on pain sensitivity 
measures, with some studies 
showing differences between 
menstrual phases273 and others 
showing no significant 
impact26,138,356. As all studies (I-
III) involved more than one 
session, data was collected from 
female participants about 
menstruation in an effort to 
ensure avoidance of systematic 
bias. 
- Current day of 
menstrual cycle 
(Study I-III) 
- Average cycle 




These particular questions have not 
been validated but reflect factors that 
individuals can estimate based on 
their last menstrual period. Without 
hormone testing, it is not possible to 
determine precisely which phase 
females were in, but the present 
measures were deemed adequate to 
understand if female participants had 
normal cycles and were roughly 
evenly distributed between phases to 
exclude clear systematic bias. 
Mood Both experimental manipulation 
of affect and the presence of 
affective disorders have been 
shown to influence pain 
experiences72,339, as well as pain 
sensitivity122,318,340. Hence, 
affective state during the session 
was thought to be important to 
assess, both to identify potential 
basal differences in affect 
between patients and controls, 
and to capture potentially 
influential changes between 
sessions. 
- Face Scale182 
(Study I-III) 








(BDI27, Study III) 
The Face Scale provides a 
unidimensional 20-point picture scale 
of facial images ranging from very 
positive (1) to very negative (20) 
expressions. It is a simple measure 
that provides a quick unidimensional 
assessment of mood. The PANAS 
was used as a more nuanced 
classification of affect, as it asks 
participants to rate the extent to 
which they currently feel each of the 
20-affective states listed. The PANAS 
has been validated to reliably capture 
two distinct affective components48,57. 
The BDI has been validated and used 
as a tool to screen for possible 
affective disorders in various 
settings27,310.  
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Factor (cont.) Rationale (cont.) Measures (cont.) Description and validity (cont.) 
Anxiety Similar to affective disorders, 
anxiety disorders also well known 
to commonly co-occur with pain 
conditions15, and artificial 
manipulation of anxiety202 or 
stress96,331 can impact pain 
experiences. 
- Spielberger 




The STAI is a 40-item scale, where 
participants rate the extent to which 
statements describe them now (state) 
or in general (trait), and which has 
been widely used in psychological 
research. It has been translated and 
validated into many 
languages1,19,76,111,185 and provides 
useful distinct characterisation of 
state and trait anxiety86.  
Pain 
Catastrophizing 
Along with anxiety and affective 
disorders, patients with chronic 
pain often have catastrophic 
thoughts about their condition. 
Such thoughts have been 
increasingly captured in 
research, for example, by using 
the Pain Catastrophizing Scale 
(PCS)312. 
- The Pain 
Catastrophizing 
Scale312 (PCS, 
Study I-III)  
The PCS is a 13-item scale of 
cognitions that may arise when one is 
in pain, on which participants rate 
how frequently they have such 
catastrophic thoughts. It has been 
used extensively in pain research and 




A u-shaped relationship is 
purported to exist between 
physical activity and clinical pain, 
suggesting that both too much 
and too little activity can be 
problematic118. Within normal 
limits, however, physical activity 
seems protective against LBP 
development125,292. In relation to 
pain sensitivity, physical activity 
also often seems protective and it 
is well-established that exercise 
can have acute positive effects 
on pain threshold measures216,275. 
Physical activity was thus 
captured to identify between-





(IPAQ, Study I-III) 
The IPAQ has been widely used and 
translated into several languages, 
offering a quick estimate of weekly 
exertion and daily sitting time337. 
Unfortunately, attempts to validate 
the IPAQ against objective activity 
data (e.g. with accelerometer or 
pedometer) have proven difficult, with 
very poor correlation between these 
measures, and studies commonly 
demonstrating over-estimation of 
activity levels by participants168. 
Reports of reliability for the IPAQ 
have also been variable with 
excellent reliability reported in healthy 
controls294 but poor reliability in CLBP 
patients47. Despite this, IPAQ 
responses have previously been 
shown to correlate with TSP and 




Appendix C. Additional Analyses 
Between-Studies  
For the sake of completeness, an additional overall analysis was conducted to compare 
between study groups for the main outcomes, and where the same methodology was used in 
all participants. In some cases, these findings contradict the individual study findings, likely due 
to the small effect sizes and addition of variability. Nevertheless, they serve as an indication of 
potential differences and similarities between the populations and LBP models investigated.  
Details of analytical methods and results for comparisons made on 
questionnaire data pooled from all studies 
 

















No differences were noted for height or 
weight either using the same analysis.  
Mood (Faces Scale, 
Past week / Now) 
2-way ANOVA 
with: Group (4), 
Session (2) for 
each variable 
No differences 
observed for either 












No differences between groups. CLBP 
patients slept more hours prior to the 
representative less painful session than 






















In RLBP, PCS score was higher during 
the painful session than the non-painful 
session (P=0.001). In DOMS, PCS score 
was lower during the painful session than 
the non-painful session (P<0.001). In the 
painful session, RLBP patients showed 
higher PCS scores than participants with 




(Sitting time / Score) 
One-way 
ANOVA with: 
Group (4) for 
each variable 
No difference 
between groups for 
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Details of analytical methods and results for comparisons made on 
clinical characteristic data pooled from all studies 
 
Characteristic Model Omnibus Test Post-hoc Comparisons 






















effect of Group: 
F2,59=17.36, P<0.001 
Pain duration was greater in RLBP 
(P<0.001) and CLBP (P=0.001) patients 
than provoked in the DOMS model. 





effect of Group: 
F2,59=10.33, P<0.001 
McGill scores were higher in RLBP 
(P<0.001) and CLBP (P=0.017) patients 









effect of Group: 
F2,59=4.43, P=0.016 
Disability was higher in RLBP (P=0.049) 
and CLBP (P=0.042) patients than 




H test with: 
Group (3) 
Significant main 
effect of Group: 
H2=17.18, P<0.001 
STarT-Back Scores were higher in 
RLBP than DOMS (P=0.008) and in 







Details of analytical methods and results for comparisons made on 
primary outcome data pooled from all studies  
 







factor: Group (4); and 
within-subject factors: 







Compared to control group: ↓ ECR & UT 
in DOMS (P<0.03), ↓ L1 & L5 in CLBP 
(P<0.04) in painful session; no significant 
differences between-groups in pain-free 
session 
Compared between sessions: no 
differences in controls (P>0.06), ↓ during 
DOMS at ECR, L1 & L5 (P<0.02), ↓ 
during RLBP at ECR, UT, L1 & L5 
(P<0.04); ↓ in more painful CLBP session 















No differences between groups in either 
session 
Compared between sessions: ↓ cPDT 
during RLBP (P=0.04) and during more 















No differences between groups in either 
session 
Compared between sessions: ↓ cPTT 











Main effect of 
Session: F3,88=12.52, 
P=0.001, η2=0.125 
Pain ratings of supra-threshold pressure 







factor: Group (4); and 
within-subjects factors: 
Epoch (3) and Session 
(2) 
Main effect of 
Epoch: F2,176=64.79, 
P<0.001, η2=0.424 
All epochs significantly different (first < 
second < third) indicating significant TSP 
demonstrated, but no differences 







factor: Group (4); and 
within-subjects factors: 
Ramp (3), Threshold 
(2) and Session (2) 
Main effect of Ramp: 
F2,176=17.72, 
P<0.001, η2=0.168 
Normalized change in cPDT and cPTT on 
ramps during and post conditioning 
stimulation were significantly higher 
overall than the repeated ramp prior to 
conditioning (P<0.001) indicating a 
normal inhibitory response to 
conditioning, but no differences 
observable between groups or sessions 
 
 
M
EG
A
N
 ELIZA
B
ETH
 M
C
PH
EE C
H
R
ISTEN
SEN
TEM
PO
R
A
L C
H
A
N
G
ES IN
 PR
O
-N
O
C
IC
EPTIVE A
N
D
 A
N
TI-N
O
C
IC
EPTIVE 
M
EC
H
A
N
ISM
S IN
 R
ELATIO
N
 TO
 TH
E EXPER
IEN
C
E O
F LO
W
 B
A
C
K
 PA
IN
ISSN (online): 2246-1302
ISBN (online): 978-87-7210-821-6
